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“equipped with his five senses, man explores the universe around him and calls the 
adventure science.”  ~edwin powell hubble, the nature of science, 1954
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Abstract
studying neurodegeneration provides an opportunity to gain insights into normal cell physiol-
ogy, and not just pathophysiology. in this thesis work the focus is on infantile neuronal ceroid 
lipofuscinosis (incl). it is a recessively inherited lysosomal storage disorder. the disease 
belongs to the neuronal ceroid lipofuscinoses (ncls), a group of common progressive neuro-
degenerative diseases of the childhood. characteristic accumulation of autofluorescent storage 
material is seen in most tissues but only neurons of the central nervous system are damaged 
and eventually lost during the course of the disease leaving most other cell types unaffected. 
the disease is caused by mutations in the CLN1 gene, but the physiological function of the cor-
responding protein the palmitoyl protein thioesterase (ppt1) has remained elusive.
the aim of this thesis work was to shed light on the molecular and cell biological mechanisms 
behind incl. this study pinpointed the localization of ppt1 in axonal presynapses of neu-
rons. it also established the role of ppt1 in early neuronal maturation as well as importance in 
mature neuronal synapses. this study revealed an endocytic defect in incl patient cells mani-
festing itself as delayed trafficking of receptor and non-receptor mediated endocytic markers. 
furthermore, this study was the first to connect the incl storage proteins the sphingolipid 
activator proteins (saps) a and d to pathological events on the cellular level. abnormal endo-
cytic processing and intracellular re-localization was demonstrated in patient cells and disease 
model knock-out mouse neurons. to identify early affected cellular and metabolic pathways 
in incl, knock-out mouse neurons were studied by global transcript profiling and functional 
analysis. the gene expression analysis revealed changes in neuronal maturation and cell com-
munication strongly associated with the regulated secretory system. furthermore, cholesterol 
metabolic pathways were found to be affected. functional studies with the knock-out mouse 
model revealed abnormalities in neuronal maturation as well as key neuronal functions includ-
ing abnormalities in intracellular calcium homeostasis and cholesterol metabolism. 
together the findings, introduced in this thesis work, support the essential role of ppt1 in 
developing neurons as well as synaptic sites of mature neurons. results of this thesis also elu-
cidate early events in incl pathogenesis revealing defective pathways ultimately leading to 
the neurodegenerative process. these results contribute to the understanding of the vital physi-
ological function of ppt1 and broader knowledge of common cellular mechanisms behind 
neurodegeneration. these results add to the knowledge of these severe diseases offering basis 
for new approaches in treatment strategies.
Keywords: neurodegeneration, lysosomal storage disease, neuronal ceroid lipofuscinosis, en-
docytosis, intracellular membrane trafficking, neuronal maturation, cholesterol metabolism, 
calcium homeostasis
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Tiivistelmä
tutkimalla sairauden aiheuttamaa hermosolujen rappeutumista saadaan tietoa solujen toimin-
tahäiriöiden lisäksi normaalista hermosolun toiminnasta. tämä väitöskirjatyö käsittelee 
incl-tautia (infantiili neuronaali seroidilipofuskinoosi). incl-tauti on peittyvästi periytyvä 
lysosomaalinen kertymätauti. se kuuluu neuronaalisten seroidilipofuskinoosien (ncl) tautiry-
hmään. ncl-taudit ovat melko yleisiä lapsuusiän eteneviä keskushermoston sairauksia, joille 
on tyypillistä autofluoresoivan materiaalin kertyminen useimpiin kudoksiin ja keskushermos-
ton hermosolujen rappeuma. incl-tauti aiheutuu virheistä CLN1-geenissä, mutta vastaavan 
palmityyli-proteiinitioesteraasi (ppt1) valkuaisaineen toiminta ja taudin syntymekanismit ovat 
huonosti tunnettuja.
tämän väitöskirjatyön tavoitteena oli selvittää incl:n taudinkuvan molekyyli- ja solutason 
mekanismeja. tässä työssä kuvattiin ppt1-valkuaisaineen tarkka paikantuminen hermosolun 
viejähaarakkeen hermopäätteissä. lisäksi selvitettiin ppt1:n merkitystä hermosolujen kyp-
symisessä ja kypsien hermosolujen toiminnassa. Kokeet incl-potilaiden soluilla osoittivat 
häiriön solunsisäisessä kalvoliikenteessä, joka ilmentyi tiettyjen endosytoottisten merkkiainei-
den hidastuneena kuljetuksena. tässä työssä yhdistettiin ensimmäistä kertaa incl-taudin ker-
tymämateriaalin proteiinit, saposiinit a ja d, solutason patologisiin muutoksiin: saposiinien 
solunsisäinen käsittelyn ja paikantumisen muutokset osoitettiin potilaiden soluissa ja muunto-
geenisen hiirimallin hermosoluissa. muuntogeenisen hiirimallin hermosoluja tutkittiin myös 
geenisiru-menetelmällä ja solun toimintaa kartoittavin menetelmin, aikaisten solutason aineen-
vaihduntareittien muutosten löytämiseksi. nämä tutkimukset osoittivat muutoksia hermosolu-
jen keskeisissä toiminnoissa:  kolesteroliaineenvaihdunnassa, kalsiumin tasapainon säätelyssä, 
hermosolujen kypsymisessä ja solujenvälisessä viestinnässä.
tässä väitöskirjassa esitetyt tutkimustulokset osoittavat ppt1-valkuaisaineen keskeisen merki-
tyksen kehittyvissä ja kypsissä keskushermoston hermosoluissa. tulokset selventävät aikaisia 
solutason tapahtumia incl-taudin synnyssä, osoittamalla toimintahäiröitä, jotka johtavat lopul-
ta hermosolujen rappeutumiseen ja kuolemaan. nämä tutkimustulokset auttavat suoraan ppt1:
n normaalin solutason toiminnan ja myös laajemmin hermosolujen rappeutumisen aiheuttavien 
tekijöiden  ymmärtämisessä. lisäksi ne edistävät ncl-tautien toimintahäiriöiden ymmärrystä 
ja luovat uusia lähtökohtia hoitomenetelmien kehittämiseen 
avainsanat: neurodegeneraatio, lysosomaaliset kertymätaudit, neuronaalinen seroidi-lipofuski-
noosi, endosytoosi, solunsisäinen kalvoliikenne, hermosolujen kypsyminen, hermosolujen ko-
lesteroliaineenvaihdunta, kalsiumin tasapainon säätely
6Review of the literature
1. Intracellular trafficking
1.1 Steps of cellular membrane trafficking
the eukaryotic cell is divided into compartments separated by membranes. the cell is sep-
arated from the external milieu by the plasma membrane and different cellular functions 
are carried out in membrane bound organelles. communication between the cell and its 
surroundings as well as between different cellular organelles occurs via vesiculo-tubular 
carriers. the carrier vesicles have different lipid and protein compositions, depending on 
their specific role in the transport process. membrane trafficking itself is a multi-step proc-
ess starting with initiation of specific vesicle coat assembly and cargo selection, in which 
membrane embedded with proteins as well as soluble content proteins are specifically 
excluded or included in the vesicle. this is followed by budding of the vesicle from the 
donor compartment and targeting to the acceptor compartment. the vesicle carrier moves 
to the acceptor membrane along cytoskeletal tracks and upon contact with the acceptor 
membrane the vesicle fuses and unloads the cargo. components involved with the vesicle 
formation and targeting are then released or recycled back to the donor compartment for 
a new round of employment (Bonifacino, and glick, 2004; mellman, and Warren, 2000; 
olkkonen, and ikonen, 2000; olkkonen, and ikonen, 2006). 
1.2 Endosomes to lysosomes - Pathways 
of endocytic transport
the intracellular membrane traffic follows two main routes: the biosynthetic/se-
cretory pathway and the endocytic pathway. these pathways are interconnected at 
several levels in the golgi apparatus and the endocytic compartments (Bonifacino 
and glick, 2004; maxfield and mcgraw, 2004; soldati and schliwa, 2006; van der 
goot and gruenberg, 2006). in the biosynthetic/secretory pathway newly synthesized 
proteins, carbohydrates and lipids are transported from the endoplasmic reticulum 
(er) through the golgi apparatus to the trans-golgi network (tgn). the folding and 
post-translational modifications of newly synthesized proteins also occur during these 
transport steps. Biosynthetic/secretory pathway cargo is then directed to the cell sur-
face or to the endosomes/lysosomes. the endocytic pathway comprises of uptake of 
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Figure 1. Intracellular Membrane Transport Pathways.
Schematic representation of major intracellular membrane trafficking pathways. Transport steps are 
indicated by arrows.
In the biosynthetic pathway anterograde traffic takes place from the ER to the Golgi complex in COPII 
coated vesicles. Retrograde traffic occurs in transport intermediates coated with COPI complexes. 
In the endocytic pathway the different cargoes are internalized through several pathways: in macro-
pinocytosis, the clathrin-dependent and non-clathrin dependent pathways, internalized vesicles are 
transported to the early sorting vesicle the early endosome. In the caveolar pathway, marked by the 
caveolin coat (not shown) the cargo first travels to the caveosome compartment and then to the early 
endosome. Housekeeping receptors, for example the transferrin receptor binding transferrin and the 
low density lipoprotein (LDL) receptor binding LDL, are recycled to the plasma membrane directly or 
through recycling endosomes. Other cargo, in particular ubiquitinated signalling receptors that are 
being down regulated, are collected within forming endosomal carrier vesicles/multivesicular bodies 
(ECV/MVB). ECV/MVBs are then transported towards late endosomes with which they fuse. The 
cargoes that are destined for degradation and also soluble lysosomal and lysosomal membrane 
structural proteins continue to lysosomes, whereas others are recycled either to the plasma 
membrane (directly or through recycling endosomes) or to the Golgi apparatus the trans-Golgi 
network (TGN)(for example the cation-independent mannose-6-phosphate receptor (CI-MPR) binding 
lysosomal enzymes). The TGN destined cargoes, together with newly synthesized proteins, can exit 
the TGN and traffic either to the plasma membrane or to late endosomes or early endosomes. 
Relatively large solid particles are taken up by phagocytosis into phagosomes, by an actin dependent 
process. Phagosomes progressively mature into phagolysosomes and then lysosomes.
Adapted from: van der Goot and Gruenberg, 2006; Soldati and Schliwa, 2006; Bonifacino and Glick, 
2004; Maxfield and McGraw, 2004
       COPII coat          COPI coat        Clathrin coat
proteins, lipids, extracellular ligands, soluble molecules and pathogens discussed in 
detail below. the major pathways of intracellular membrane trafficking are repre-
sented in figure 1.
81.3 Pathways of Endocytosis, internalization
endocytosis is a cellular process for internalization of cargo from the exterior of the 
cell and transport to specific destinations inside the cell. small essential molecules in-
cluding ions, carbohydrates and amino acids can traverse the plasma membrane (pm) 
through specific channels, ion exchangers and adenosine triphosphate (atp) powered 
pumps. however, larger macromolecules utilize a different mechanism, endocyto-
sis, in which the plasma membrane invaginates into the interior of the cell forming 
transport vesicles. endocytic uptake is divided into to two forms according to the 
endocytosed cargo: phagocytosis, or cell eating, is initiated by the plasma membrane 
climbing up to encompass large cargo followed by intake. in pinocytosis/fluid phase 
endocytosis, or so called cell drinking, the membrane collapses inward. this process 
is actin dependent and involves the rho family gtpases. (conner and schmid, 2003b; 
perrais and merrifield, 2005). the current view is that the plasma membrane contains 
distinct lipid and protein domains and these so-called hotspots favour specific types of 
internalization (de matteis and godi, 2004; glebov, et al. 2006; parton, et al. 2006).
1.3.1 Phagocytosis
phagocytosis is the uptake of relatively large particles, 300 nm to several microm-
eters in diameter, such as large debris (e.g. apoptotic cells, deposits of fat) by an 
actin-dependent process. this pathway is also utilized by pathogens such as yeast and 
bacteria to gain access into the cell. the process of phagocytosis occurs most robustly 
in specialized cells such as macrophages, but most cells are capable of low levels of 
phagocytosis (eskelinen, 2005). receptors on the surface of phagocytic cells bind 
particles either directly or indirectly via antigen-bound antibodies. these receptors 
are capable of activating their own uptake and receptor binding triggers a signaling 
cascade involving activation of small gtpases, which results in actin assembly and 
formation of cell surface extensions. these actin- rich cellular extensions fuse up 
around the antigen and engulf it entirely forming a phagosome. the phagosome sub-
sequently matures and fuses with lysosomes. (conner and schmid, 2003b; eskelinen, 
2005; stuart and ezekowitz, 2005)
91.3.2 The pinocytic pathways of internalization
pinocytosis is divided in four different subtypes: macropinocytosis, clathrin-mediated 
endocytosis, clathrin-independent endocytosis and caveolae-mediated endocytosis. 
macropinocytosis is the actin-dependent formation of large vesicles (from <0,2µm 
to over 1µm), which enable internalization of large quantities of fluid-phase solute 
from the extracellular milieu. in most cell types, an exogenous stimulus is required 
to induce macropinocytosis, however dendritic cells constitutively macropinocytose 
large quantities of exogenous solute as part of their function in the immune response 
(norbury, 2006).
1.3.3 Clathrin-mediated endocytosis
clathrin-mediated endocytosis is a constitutive process in all mammalian cells. it is 
initiated at clathrin-coated pits that arise from pre-determined pm hotspots. the clath-
rin-coated pits are dynamic structures, undergoing exchange of coat protein compo-
nents as they form allowing rapid production of multiple vesicles (Bonifacino and 
lippincott-schwartz, 2003; edeling, et al. 2006; Kaksonen, et al. 2006; perrais and 
merrifield, 2005). the process of clathrin-coated vesicle formation can be divided 
into three steps 1) assembly of clathrin into a polygonal lattice and formation of coat-
ed pits, 2) invagination of coated pits, and 3) pinching-off of the coated vesicles. 
this process involves interactions of adaptor proteins with the plasma membrane and 
clathrin as well as several accessory proteins and phosphoinositides. individual as-
sembly units of clathrin, called triskelions, form lattices that assemble from a soluble 
pool of clathrin and associated adaptors to form a polygonal basket structure. the 
most abundant adaptor protein is the heterotetrameric protein ap-2 (adaptor or as-
sembly protein-2)(conner and schmid, 2003a). several accessory proteins are also 
implicated in the formation of clathrin-coated vesicles and recruiting ap-2 to the pm, 
such as ap180/calm, epsin, eps15, dynamin and endophilin. in neuronal cells neu-
rotransmitter secretion synaptotagmins have been proposed to act as general docking 
sites for coated pit formation (diril, et al. 2006; Zhang, et al. 1994). the membrane 
factors that define the assembly sites include at least phosphoinositides. they are 
dynamically generated and broken down on the inner leaflet of the pm, and all adap-
tor proteins capable of promoting clathrin assembly have the ability to interact with 
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these lipids. ptdins(4,5)p2 and ptdins(3,4,5)p3 have been shown to be central for 
constitutive as well as induced endocytosis (martin, 2001). cholesterol is also as-
sumed to contribute to invagination of coated pits since cholesterol depletion affects 
the ability of endocytic proteins, such as ap-2 and dynamin, to participate in lattice 
rearrangements to induce membrane invaginations (subtil, et al. 1999). the multido-
main gtpase dynamin has been implicated in multiple steps during clathrin mediated 
vesicle formation and it is central in mediating fission of the coated pit and release 
of the clathrin coated vesicle (hill, et al. 2001). cargo uptake to clathrin coated vesi-
cles is regulated by several factors. surface proteins can enter coated pits initially by 
chance and then be captured specifically by coated-pit components. entry can also be 
achieved by binding to targeting proteins mediating selective transport to the coated 
pits. receptor-mediated endocytosis can be either constitutive or stimulus induced. 
the sorting activity of the constitutive pathway is based on the recognition of a pep-
tide sequence in the receptor termini. examples of receptors utilizing the constitu-
tive pathway include the transferrin receptor (tfr) and the low density lipoprotein 
receptor (ldlr). the signal-induced pathway sorting is mediated by adaptors and 
covalent protein modifications that facilitate receptor internalization. a well defined 
example of a receptor exploiting the signal induced pathway is a receptor tyrosine 
kinase (rtK) the epidermal growth factor (egf) receptor. rtKs possess an intrinsic 
protein tyrosine kinase activity and upon ligand binding two monomeric receptors 
dimerize and conformation change is proposed to lead to exposure of endocytic motifs 
for endocytic adaptor binding (Burke, et al. 2001; lemmon, et al. 1997).
1.3.4 Caveolin-mediated endocytosis
the caveolae are plasma membrane invaginations 50-80nm in diameter, coated by the 
caveolin-1, -2 and -3 proteins and rich in the ‘lipid raft’ components cholesterol and 
sphingolipids. it has been shown that caveolae- and lipid raft-mediated endocytosis 
plays roles in cell adhesion and anchorage-dependent cell growth; however underly-
ing mechanisms are poorly understood. cargo entering the cells via this pathway in-
cludes extracellular ligands (such as folic acid, albumin and interleukin-2), membrane 
components), glycosphingolipids and gpi (glycosylphosphatidylinositol)-anchored 
proteins and bacterial toxins. also several viruses (simian virus 40, polyoma virus 
and echovirus 1) employ this pathway to gain entry into the cells (pelkmans, 2005). 
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caveolae/raft-mediated endocytosis is thought to be initiated by the clustering of lipid 
rafts and the formation and/or sequestration into caveolae. this leads to increase of 
local cholesterol concentration inducing membrane curvature aided by concomitant 
clustering of proteins (presumably caveolin-1) associated with the cytosolic leaflet of 
lipid rafts. (Bacia, et al. 2005; rothberg, et al. 1992). also some evidence on virus 
entry studies suggest the existence of pre-assembled caveolar vesicles, termed caveo-
somes, fusing with the pm and mediating virus particle binding and entry (pelkmans, 
2005; pelkmans and Zerial, 2005). in addition, caveolin dependent internalization 
also involves proteins regulated by phosphorylation of tyrosines by respective kinases 
leading to local actin polymerization and dynamin recruitment (pelkmans and Zerial, 
2005). the caveolae pinch off the pm and once inside the cell transfer their cargo 
into caveosomes that receive cargo exclusively from the caveolae mediated pathway. 
inside the cell caveolar vesicles also dynamically dock on and fuse with the early 
endosomes, however in this kiss-and-run type interaction caveolar vesicles maintain 
their caveolin coat (pelkmans, et al. 2004). 
1.3.5 Clathrin- and caveolin independent internalization
also endocytic pathways that do not require clathrin- or caveolin coats have been 
described. these pathways bypass the conventional endocytic organelles and con-
verge with the caveolar pathway by utilizing the caveosomes as intermediates. it is 
not clear if these routes are independent cellular pathways or in fact variations of a 
common route. they are dependent on large amounts of the so called raft lipids. the 
rafts are highly ordered membrane microdomains within the bilayer. these ordered 
microdomains usually rich in glycosphingolipids and cholesterol are thought to ap-
pear independent of proteins and resulting from partitioning coefficients of particular 
lipid species (simons and toomre, 2000). rafts by themselves cannot however be 
regarded as specific markers of these clathrin- and caveolin independent pathways 
since multiple endocytic mechanisms are used to internalize lipid raft components or 
molecules that preferentially partition into rafts (pelkmans, 2005). 
1.4 Transport along the endocytic route
at internalization to the cell the cargo enters the endosomal system. it is a network 
of organelles and vesicular intermediates that differ in biochemical composition and 
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localization within the cell. the carriers in the endocytic pathway, from endosomes 
to lysosomes, can be distinguished by several aspects including: a) morphology b) 
specific membrane, protein and lipid composition c) intralumenal ph d) the temporal 
dimension of a specific cargo reaching the compartment. a plethora of proteins are 
required for correct transport along the endocytic pathway but also membrane lipid 
microdomains, patches of membrane where certain lipids and proteins are enriched, 
formed locally on the compartments coordinate the transport process. the phos-
phoinositides (pips) are essential components in this process. they are distributed 
along the endocytic pathway in a spatially and temporally specific manner by spe-
cific phosphatidylinositol kinases and phosphatases. (di paolo and de camilli, 2006; 
lindmo and stenmark, 2006; perrais and merrifield, 2005). transport steps follow-
ing the actin-dependent internalization process are primarily microtubule-dependent 
(Qualmann and Kessels, 2002). the following step after internalization is delivery to 
the early endosomes (ee), that are vesiculo-tubular organelles, identified by resident 
membrane protein eea1 and associated small rho family gtpase rab5, usually lo-
cated in the peripheral parts of the cell having the ability to go through homotypic fu-
sion with other ees. from there the cargo is sorted either to the degradative pathway 
to the lysosomes or recycled back to the plasma membrane directly or through recy-
cling endosomes identified by resident rabs 5, 4 and 11. cargo entering the recycling 
pathway consists mainly of housekeeping receptors such as transferrin receptor (tfr) 
and low density lipoprotein receptor (ldlr). also transport to the tgn from ees 
is possible and these cargoes, together with newly synthesized proteins, can exit the 
tgn and traffic either to the plasma membrane or to late endosomes, and to a minor 
extent to early endosomes. cargo in the degradative pathway (for example low den-
sity lipoprotein ldl and egfr) is transported form the ees multivesicular carrier 
vesicles (ecv/mvBs) that acquire their internal membrane profiles as a result of the 
inward invagination of the delimiting membrane containing enriched phosphatidyli-
nositol 3-phosphate (pi3p) and cholesterol. Ubiquitinylation of receptors, destined 
for downregulation, targets them for sorting into multivesicular bodies.  ecv/mvBs 
fuse with late endosomes enriched in lysobisphosphatidic acid (lBpa) and associated 
rab7 and rab9. cargo, such mannose 6-phosphate receptors (m6prs), can be are re-
cycled back to the tgn from late endosomes. Upon fusion with the lysosome, cargo 
is degraded. (perrais and merrifield, 2005; soldati and schliwa, 2006; van der goot 
and gruenberg, 2006). the lysosome is a highly acidic organelle having a delimiting 
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membrane and contains large numbers of lysosomal hydrolases. lysosomal acidifica-
tion is achieved through the v-type h+ -atpase complex that powered by atp translo-
cates protons. over half of the lysosomal membrane mass is composed of membrane 
proteins lamp-1, lamp-2, limp-1 and limp-2 (Kornfeld and mellman, 1989). 
lysosomes also lack the cation-dependent (46kda mpr) and cation independent 
(300kda ci-mpr) mannose 6-phosphate receptors.  lysosomes have various func-
tions including down-regulation of cell surface receptors, release of nutrients from 
endocytosed material, turnover of cellular proteins, repair of membranes, inactivation 
of pathogens, loading antigens for presentation onto mhc class ii molecules in anti-
gen presenting cells (eskelinen, et al. 2003). 
1.5 Membrane trafficking in neurons 
and synaptic transmission
the nerve cells generate electrical signals to convey information. these signals are 
transmitted to other cells via synaptic connections. neurotransmission is dependent 
of the electrical potential of the cell membrane, and neurotransmission is mediated 
by the action potential. the action potential is initiated at the cell body and travels to 
the presynaptic nerve terminal.  the action potential induced transient increase in na+ 
permeability results in membrane depolarisation and the opening of ca2+ channels at 
the presynaptic membrane. the calcium influx triggers fusion of the synaptic vesicles 
(svs) to the presynaptic membrane and neurotransmitter is released. neurotransmit-
ters traverse the synaptic cleft and bind to their respective receptors on the postsyn-
aptic membrane and transfer the signal to the postsynaptic neuron. at the presynaptic 
neuron, excess free calcium is sequestered intracellularly or removed to the extracel-
lular space and transient rise in K+ permeability repolarizes the neuronal membrane 
reconstituting the resting state. (südhof, 2004)
neurotransmission depends on the regulated release of transmitter molecules form 
specialized secretory vesicles in the synapse. the packaging of cargo into these secre-
tory vesicles is carried out by vesicular transporters and the activity of the transporters 
affects levels of neurotransmitter available thereby affecting synaptic function. the 
transporters all function by a same principle: a vacuolar proton pump driven with atp 
creates an electrochemical gradient enabling active transport of neurotransmitters into 
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svs. each neurotransmitter group has their own transporters. (ahnert-hilger, et al. 
2003) synaptic vesicles are clustered to the presynaptic active zone by scaffolding 
proteins aided by several adaptors. these processes are described in detail in chapter: 
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presynaptic terminal differentiation, transport and assembly. the svs are arranged 
into different functional pools consisting of varying types and number of vesicles 
depending on neuron type (rizzoli and Betz, 2005). the docked pool or the pool of 
vesicles that is drawn from by the initial action potential is referred to as the readily-
releasable pool (rrp) (saviane and silver, 2006). it is replenished from the recycling 
or reserve pool (rp), also called the endo/exo (endocytosis and exocytosis) cycling 
pool (ecp) (saviane and silver, 2006). the remaining vesicles are grouped into the 
non-recycling pool or the cycling-dead pool (rizzoli and Betz, 2005). in resting nerve 
terminals, synaptic vesicle pools are tethered in place by a a network of filaments 
and cytoskeletal components. stimulation is proposed to increase vesicle mobility 
for controlled fusion events via synapsins that form a link between the svs and the 
actin cytoskeleton and are activated by calcium (llinas, et al. 1985). the vesicles are 
primed making them competent for ca2+ triggered fusion. vesicle priming, the ex-
tent of snare (soluble n-ethylmaleimide sensitive fusion (nsf) attachment protein 
receptor) fusion complex formation and/or the distance to the next calcium channel 
affect the fusion probability of a given docked vesicle (schweizer and ryan, 2006). 
the fusion snare complex drives the fusion of the trafficking synaptic vesicle 
membrane to the target membrane following target recognition. the complex form-
ing proteins are highly conserved throughout eukaryotic evolution and function in 
most membrane fusion events. 36 members of the snare superfamily are present in 
humans. (Bonifacino and glick, 2004; Jahn and scheller, 2006) the snare proteins 
function in related pairs, with one partner being localized on the vesicle and the other 
set on the target membrane. correct assembly of the snare pair is also involved 
in establishing fusion specificity. the snare driven membrane fusion is powered 
by free energy that is released during the formation of a four-helix bundle of the 
snare complex. the establishment of the bundle, or trans-snare complex, leads 
to a tight connection of the fusing membranes, and initiates the membrane merger. 
Upon membrane fusion, the snares are present on the same membrane in a cis-com-
plex. the snare proteins are recycled for repeated cycles of membrane fusion and 
the recycling is achieved through the dissociation of the helical bundle by the aaa+ 
protein nsf (n-ethylmaleimide-sensitive factor) and snap (soluble nsf-attachment 
proteins)(Jahn and scheller, 2006). neuronal snares include synaptotagmins (syt): 
syt1 is required for fast ca2+ mediated exocytosis, whereas syt3, 6 and 7 are impli-
cated in slow asynchronous release (sugita, et al. 2002). synaptic vesicles also have 
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their own rab proteins (rab3a-d, rab5 and rab11), that mediate membrane attach-
ment via effector molecules.
Upon fusion of the vesicles and release of neurotransmitters the svs are endocytosed 
and locally recycled for another round of employment within nerve terminals. it is 
not fully understood how the exocytic process triggers endocytosis but two different 
mechanisms have been suggested: sv proteins appearing on the pm at exocytosis 
drive their own retrieval through adaptor-recognition of retrieval motifs on the cyto-
plasmic tails of the proteins or elevation in intracellular calcium by the action potential 
initiating exocytosis activates the endocytic machinery. the endocytosis is carried out 
through alternative routes: 1) slow clathrin mediated direct- or intermediate utilizing 
endosomal recycling 2) fast direct kiss-and-stay recycling or kiss-and-run recycling 
through the reserve pool. (schweizer and ryan, 2006; südhof, 2004)
1.6 Protein palmitoylation: regulator of function and trafficking
protein palmitoylation, the addition and removal of the fatty acid palmitate to pro-
teins, has a major role in controlling and modulating protein-membrane interactions, 
protein trafficking, and enzymatic activity (huang and el-husseini, 2005; linder and 
deschenes, 2007). palmitoyltransferases that add palmitate to proteins were first iden-
tifed in the yeast Saccharomyces cerevisiae and Drosophila fly (linder and deschenes, 
2003). several palmitoyltransferases have since then also been identified in mamma-
lian systems. these include mouse and human dhhc proteins, sharing a cysteine 
rich asp-his-his-cys (dhhc) motif (fukata, et al. 2004; huang, et al. 2004). While 
mammalian palmitoylating dhhc proteins have been identified in the er, golgi and 
the plasma membrane data is still limited on the identity as well as localization of 
depalmitoylating thioesterases. to date only two palmitate removing enzymes have 
been identified. the acylprotein thioesterase apt1 resides in the cytosol and removes 
palmitate from membrane associated proteins (duncan and gilman, 1998). the other 
palmitoyl removing enzyme is palmitoyl protein thioesterase 1 (ppt1). it is the only 
enzyme described to date that depalmitoylates proteins destined for degradation in the 
lysosomes (lu and hofmann, 2006). ppt1 has possible additional roles in the neu-
rons because a wide range of proteins with different characteristics are palmitoylated. 
therefore it is likely that multiple substrate specific acyltransferases and thioesterases 
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act in multiple subcellular compartments. (linder and deschenes, 2003; linder and 
deschenes, 2007). a schematic representation of the protein palmitoylation/depalmi-
toylation cycle is presented in figure 3.
Schematic representation of palmitoylation of cellular proteins.
A) The 16-carbon lipid, palmitate, is attached to the thiol group ( SH ) of a cystein amino acid residue.
B) The addition of palmitate from coenzyme A (CoA) to the target protein is catalyzed by protein
acyltransferases (PAT). The removal of palmitate is mediated by acylprotein thioesterases (APT). 
Palmitoylated proteins destined for degradation in the lysosomes are cleaved into peptides by
various proteases from which palmitate is consequently removed.
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Figure 3. Protein Palmitoylation
1.6.1 Reversible palmitoylation and dual lipid modifications
protein palmitoylation is a reversible modification that allows dynamic regulation of 
protein function. palmitoylation or s-acylation is a post-translational modification in 
which a 16 carbon saturated fatty acid palmitate is incorporated into the side chain of 
cysteine residue of a newly synthesized protein post-translationally. proteins that are 
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palmitoylated often also carry additional lipid modifications. for example signal-trans-
duction proteins, such as guanine-nucleotide-binding g protein subunits and non-recep-
tor tyrosine kinases, are reversibly modified with a co-translational n-myristoylation 
followed by post-translational palmitoylation. (resh, 1999). the ras superfamily small 
gtpases are also reversibly modified but have a more complex series of post-transla-
tional modifications leading to prenylation, a farnesyl or a geranylgeranyl isoprenoid 
modification, followed by palmitoylation (schafer and rine, 1992; Zhang and casey, 
1996). the hedgehog family proteins have, in contrast to the aforementioned, irrevers-
ible dual-lipid modifications with cholesterol at the c-terminus and palmitate in the 
n-terminus (mann and Beachy, 2004; miura and treisman, 2006). the thioester bond 
formed in s-acylation is labile enabling palmitate removal (magee and courtneidge, 
1985; mcilhinney, et al. 1985). depalmitoylation, or removal of the palmitate moiety, 
occurs when an enzyme hydrolyses the thioester bond between the carboxyl end of the 
fatty acid and the sulfhydryl group of the cysteine residue. the palmitate turnover can 
be constitutive or regulated (smotrys and linder, 2004).
1.6.2 Cellular targets of palmitoylation
Both integral and peripheral membrane proteins can be palmitoylated. palmitoyla-
tion renders the target protein virtually always membrane bound, whereas other fatty 
acid modifications, such as prenylation and myristoylation, target proteins to the cy-
toplasm as well as to the membranes (casey, 1995). a vast number of proteins are 
known to be palmitoylated and the palmitoylproteome, or total set of known and pre-
dicted palmitoylated proteins in a cell, has grown extensively in recent years. the 
classical targets of palmitoylation include g-protein subunits and g-protein coupled 
receptors (dunphy and linder, 1998), src family protein tyrosine kinases (milligan, et 
al. 1995), acetycholinesterase (roberts, et al. 1988), nitric oxide synthase (robinson, 
et al. 1995) and the transferrin receptor (Jing and trowbridge, 1987). recent additions 
comprise snares, kinases, protein phospatases, yeast vacuole proteins and amino 
acid permeases (reviewed in linder and deschenes, 2007). moreover, palmitoylation 
is remarkably ubiquitous in the nervous system. palmitoylated proteins in neurons 
include growth-associated protein-43 (gap-43), synaptosomal protein snap-25, the 
postsynaptic density protein psd-95, ampa- and gaBa receptor subunits (hayashi, 
et al. 2005; Keller, et al. 2004; lu and hofmann, 2006). the synaptic vesicles contain 
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all the components for palmitoylation of snare proteins, however the exact sites 
where palmitoylation and depalmitoylation occur in cells are still unclear. the neu-
ronal snare snap-25 (25-kda synaptosome-associated protein), has two snare 
motifs joined by a palmitoylated linker. also snares that have transmembrane do-
mains can be palmitoylated. this has been shown to protect snares from ubiquitin-
pathway mediated degradation (valdez-taubas and pelham, 2005).
1.6.3 Palmitoylation in regulating intracellular traffic
palmitoylation regulates transport of proteins between organelles, targeting of pro-
teins into the nerve terminals, traffic in the terminals and also clustering of proteins 
in specific membrane compartments (linder and deschenes, 2007). one of the best 
characterized examples of intracellular targeting by palmitoylation are the ras super-
family small gtpases. h-ras, carrying two palmitoylation sites, and n-ras carrying 
one palmitoylation site, reside on the plasma membrane, golgi or er depending on 
their palmitoylation statuses (roy, et al. 2005). moreover, their palmitoylation status-
es also affect their membrane microdomain localization on the membrane in question: 
a single palmitoylation of h-ras on cys184 results primarily in golgi localization. 
however, the fraction residing on the plasma membrane undergoes gtp-regulated 
lateral diffusion between cholesterol rich microdomains/lipid rafts and cholesterol-
independent microdomains, similar to dually palmitoylated h-ras. By contrast, single 
palmitoylation of h-ras on cys181 leads to efficient plasma membrane localization, 
but this form of h-ras localizes solely to lipid rafts. in this way, the cys181 palmi-
toylated form of h-ras behaves like n-ras (roy, et al. 2005). 
2. Neuronal maturation
2.1 Establishment and maintenance of neuronal polarity 
mature neurons are highly polarized cells that have the ability to transmit intercellular 
signals from one compartment to another. most neurons have a single axon and sev-
eral dendrites and the axonal and somatodendritic compartments are formed during 
neuronal maturation. the different cellular compartments aquire distinct structural 
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and molecular properties guided by several polarity regulating molecules. cultured 
hippocampal neurons develop and maintain a single axon and several dendrites and 
they have been used extensively to characterize the molecular mechanims underlying 
neuronal polarization. In vitro maturation of these neurons takes about seven days and 
is divided into five stages: 1) after plating the neurons form a protrusion veil and few 
spikes. 2) spikes are transformed into short neurites of equal length. 3) one neurite 
starts growing rapidly forming an axon and establishing neuronal polarity. 4) remain-
ing protrusions aquire dendritic characteristics. 5) neurons establish synaptic contacts 
forming a network (reviewed in craig and Banker, 1994).  neurons have an intrinsic 
polarization program but also extracellular cues and their downstream signal regulate 
polarization in physiological surroundings. recent evidence suggests that these are 
regulated by pi 3-kinase, rho family gtpases, cytoskeleton related proteins and the 
par complex (arimura and Kaibuchi, 2005). 
2.1.1 Axon specification
several mechanisms have been proposed to trigger the initial event of neuronal po-
larization, or axon specification. these include exclusion of polyribosomes from the 
growing axon and higher concentration of intracellular membranes in the axonal 
growth cone (deitch and Banker, 1993) or the localization of axon specific proteins 
such as gap-43 (goslin, et al.  1988). regulating microtubule assembly, the endocy-
tosis of adhesion molecules, and the reorganization of actin filaments are key events 
in axon elongation. the centrosome and directional microtubule assembly have been 
shown to guide the early neuronal polarization. in cultured hippocampal neurons, the 
centrosome, golgi apparatus, and endosomes cluster together to the area where the 
axon will form and prevention of the centrosome functions inhibit neurite formation 
(de anda, et al. 2005). however, this effect may rather result from the disturbance of 
the centrosome controllers, microtubules, dynein and pi 3-kinase- and cdc42-medi-
ated signals and not the centrosome position per se (arimura and Kaibuchi, 2005). 
pi 3-kinase and its lipid product [pi(3,4,5)p3; pip3] or pip3 are essential for neu-
ronal polarization. pi 3-kinase is specifically activated at the tip of the future axon 
and application of a pi 3-kinase inhibitor totally prevents axon formation (shi, et al. 
2003). axon elongation requires rearrangement of the cytoskeletal components, the 
actin filaments, intermediate filaments and microtubules, which are regulated by rho 
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family gtpases. dynamic changes in actin filaments in the tip of the growing axon, 
allowing microtubule growth into distal parts of the growth cone, have been impli-
cated (Bradke and dotti, 1999). putative rho family gtpases for axon specification 
includes cdc42 (cell division cycle 42), rac1, and rhoa (reviewed in govek, et al. 
2005). pi 3-kinase activity is also required for proper localization of cdc42 and the 
par-kinesin polarity complex at tips of the axon (nishimura, et al. 2005; shi, et al. 
2003). during axon elongation vesicles are targeted to the growth cone to promote 
neurite outgrowth and synaptogenesis. the secretory pathway exocyst complex is an 
essential macromolecule in this process. it consists of eight subunits which interact 
in a polar fashion with the target membrane, rab gtpases associated with secretory 
vesicles and the cytoskeleton, to mediate vesicle fusion (vega and hsu, 2001). 
2.1.2 Polarized transport and targeting of neuronal traffic
neurons must retain their polarity throughout their lifespan in order to effectively con-
vey intercellular messages across the cell.  intracellular trafficking is important not only 
to the establishment but also the maintenance of neuronal polarity. however, neuronal 
trafficking mechanisms are still relatively poorly understood. the major regulator seems 
to be targeting of transport by the specific organization of microtubules in the neurons. 
in the axon the microtubules are organized in only one orientation with the plus end of 
the tubule facing the distal part of the axon, whereas in dendrites the microtubules are 
in a mixed orientation (Baas, et al. 1988; Burton and paige, 1981). proteins and cargo 
containing vesicles are selectively transported from the soma to the neuronal extensions 
along the microtubules utilizing kinesin and dynein family motor proteins (reviewed in 
hirokawa and takemura, 2005). the transport from the cell body towards the exten-
sions is mainly mediated by kinesin superfamily proteins (Kifs) (aizawa, et al. 1992), 
whereas dynein superfamily proteins carry out retrograde transport towards the soma 
(harada, et al. 1998). proteins regulating neuronal polarity are specifically transported 
to the growing axon. for example par3 is known to be transported to the tip of the axon 
by Kinesin-2 through direct interaction with Kif3a (nishimura, et al. 2004). some 
Kifs are always dendritic, for example the plus end directed Kif21B (marszalek, et al. 
1999) whereas others such as Kif21a and Kif5 (marszalek, et al. 1999; nakata and 
hirokawa, 2003) are axonal. this differential distribution suggests that Kifs are able to 
recognize the microtubule population in the axonal initial segment, but the molecular 
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mechanisms underlying this function are currently not understood (Winckler, 2004). in 
addition to the Kif mediated axonal targeting also other mechanisms have been identi-
fied. sorting at the tgn level has been implicated: some axonal cargoes, for example 
the presynaptic protein synaptophysin, are sorted to axonal cargo-enriched transport 
carriers vesicles in the trans-golgi network and are transported anterogradely along the 
axon in distinct post-golgi carriers (Kaether, et al. 2000). also preferential domain spe-
cific fusion involving snare complexes and their regulators may serve as targeting 
mediators (foletti, et al. 1999; gerst, 2003).
palmitoylation acts as a targeting signal to axons for growth associated protein 43 
(gap-43), paralemmin (Kutzleb et al. 1998) and glutamate decarboxylase gad65 
(Kanaani, et al. 2002; Kanaani, et al. 2004; Kutzleb, et al. 1998). palmitoylation is 
also a key factor in neuronal development. palmitoylation affects dendritic spine for-
mation via paralemmin aided with rho family gtpases cdc-42 and arf6 (gauthier-
campbell, et al. 2004). it also regulates axonal pathfinding, synapse formation and 
growth-cone maturation via adhesion molecules ncam140, dcc (axon guidance re-
ceptor deleted in colorectal cancer) and growth associated protein gap-43 and post-
synaptic receptor and ion channel clustering (christopherson, et al.  2003; craven, et 
al. 1999; herincs, et al. 2005; Kim, et al. 2004; niethammer, et al. 2002). 
endocytic processes play a role in axon outgrowth and targeting of intracellular traffic 
in neurons. during axon outgrowth, new membrane and associated proteins are insert-
ed in the growing tip using molecular machinery distinct from synaptic vesicle fusion 
machinery (futerman and Banker, 1996; martinez-arca, et al. 2000). for example, 
endocytic proteins syntaxin13 and vamp7 are required for axon outgrowth (alberts 
and galli, 2003; alberts, et al. 2003; hirling, et al. 2000). their effect is postulated 
to be local in growth-cone associated endosomes controlling adhesion-detachment 
cycles (alberts, et al. 2003).  another option is that endocytosed material is in fact 
receptors that have ‘leaked’ into the incorrect domain and are transported from the 
somatodendritic compartment to the axon and this transport is regulated by syntaxin 
and vamp7 (Winckler, 2004). transcytosis has also been described in neurons: neu-
rotrophins are endocytosed at axonal sites and transported back to the cell body for 
participation in cellular signaling events (Barker, et al. 2002; ginty and segal, 2002). 
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conversely, transferrin and polymeric ig receptor (pigr) travel from the dendrites to 
the axon (de hoop, et al. 1995; hemar, et al. 1997; Jareb and Banker, 1998).
many factors affect intracellular targeting and polarization in neurons. particularly axon-
al targeting seems to be a complex multi-step process with various degrees of selectivity 
at different steps and also corrective functions. even though the physiological function 
and relevance of these steps still remains elusive, modulation of pathway choices would 
allow dynamic changes in cargo targeting and moreover neuronal function.   
2.2 Presynaptic terminal differentiation, transport and assembly
during neuronal maturation synapses are assembled into a highly differentiated and 
organized structure containing the presynaptic terminal and corresponding postsyn-
aptic part. the major events in presynaptic terminal differentiation are the formation 
of the active zone and the clustering of synaptic vesicles. the active zone is formed 
by closely packed synaptic vesicles near the presynaptic plasma membrane opposite 
to the postsynaptic density. in mature chemical synapses the synaptic vesicles medi-
ate neurotransmitter release and are recycled in the area flanking the active zone. 
in this perisynaptic zone, synaptic vesicles that have undergone fusion are retrieved 
by clathrin-mediated endocytosis (gundelfinger, et al. 2003). the three main com-
plexes enabling release of contents and recycling of synaptic vesicles are 1) the core 
snare which mediates vesicle docking and fusion 2) the exocytosis complex in-
cluding munc18/Unc-, munc13/Unc-13, and synaptotagmin and 3) the complex of 
variable contents that tethers and organizes vesicles and endo/exocytosis machineries 
in the active zone. these complexes are explained in detail in the previous chapter 
describing the synaptic vesicle cycle. associated with the function of these complexes 
are also the cytoskeletal proteins, scaffolding proteins, voltage gated calcium chan-
nels and cell adhesion molecules. interactions between these main players create a 
network that organizes the structure and function of the presynaptic terminal.  
2.2.1 The active zone components
to date, five active zone cytomatrix (caZ) enriched protein families have been identi-
fied and functionally analyzed: Unc13/munc13 proteins, rims (rab3-interacting mol-
ecule),	Bassoon	and	Piccolo,	ELKS	(ERC/CAST),	and	liprins-α	(Schoch	and	Gundelf-
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inger, 2006). through specific interactions, these proteins form a scaffold at the active 
zone and organize the release and retrieval of synaptic vesicles and regulate changes in 
neurotransmitter release in short-term and long-term forms of synaptic plasticity.
at the active zone two major proteins are responsible for scaffolding in the presynap-
tic cytomatrix (caZ): Bassoon and piccolo are among the earliest protein components 
present at the developing presynapses. (garner, et al. 2000).  the active zones are 
pre-assembled in neuronal cell bodies and transported as so-called piccolo-Bassoon 
transport vesicles (ptvs) to sites of synaptogenesis (antonova, et al. 2001; fejtova 
and gundelfinger, 2006;).  also aZ proteins such as syntaxin, snap25, and n-cad-
herin, are carried along axons in ptvs (Zhai, et al. 2001).  synaptic assembly is initi-
ated by local trapping or maturation of different presynaptic components following 
synaptic target recognition (ahmari, et al. 2000; shapira, et al. 2003).  in addition to 
stable components of the active zone various components undergo redistribution with 
synaptic activity (tao-cheng, 2006). rims (rab3-interacting molecule family) me-
diate the insertion of ptv contents to the plasma membrane (dulubova, et al. 2005; 
shapira, et al. 2003). rims can also interact with other multiple synaptic proteins for 
example	ELKS,	Piccolo,	synaptotagmin,	SNAP25,	Liprin-α	and	N-type	voltage-de-
pendent calcium channels (reviewed in schoch and gundelfinger, 2006). in mammals 
elKs also called cast (caZ-associated structural protein) proteins are required for 
correct localization of rim proteins at the active zone, calcium channel clustering and 
vesicle release (Kaufmann, et al. 2002; Kittel, et al. 2006).
the highly regulated distribution of active zones in developing neurons is crucial for the 
correct function of neuronal circuits. the development of neuronal arborizations must in-
clude mechanisms to regulate key features such as the spacing of terminals, the frequency 
of branching, and the distribution and density of release sites. Yet, many of these regula-
tory mechanisms and their specific features are still poorly understood. endocytic events 
have been suggested to have a role in the controlling of these events.  evidence in several 
Drosophila endocytosis mutants shows that impaired endocytosis causes formation of ex-
tra satellite synapses. the exact mechanism behind this is unknown but several hypotheses 
exist on the underlying reasons: extra boutons may be an indirect consequence of accu-
mulation of excess surface membrane. also possible involvement of endocytic proteins in 
cytoskeletal arrangements has been suggested (dickman, et al. 2006). 
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2.3 Calcium metabolism and neuronal maturation
the calcium ion is a ubiquitously employed intracellular messenger. it is a key regula-
tor of central cellular events in development, neuronal function, secretion and control-
led cell death. exceeding concentrations of calcium are toxic to cells and too small 
concentration causes cellular dysfunction and therefore the amount of intracellular 
free calcium needs to be tightly regulated. cells regulate their intracellular calcium 
concentrations within a narrow physiological range aided by an array of cell surface 
and intracellular receptors, channels, pumps, and organelles (reviewed in Berridge, et 
al. 2000). in addition, especially different neuron types utilize various calcium bind-
ing proteins to buffer changes in intracellular calcium (schwaller, et al. 2002). ele-
ments of intracellular calcium signalling are described in figure 4.
2.3.1 Calcium signalling in the formation of synapses 
neuronal activity and communication with neighbouring cells influences neuronal 
development, and even though signalling mechanisms that link activity to morphol-
ogy are not well understood, it is evident that calcium plays a key role. in developing 
neurons initial synaptic contact leading to signalling events results in elevation of in-
tracellular calcium levels.  this is achieved through influx of extracellular calcium or 
release of calcium from intracellular stores. activity induced fluctuations in intracel-
lular calcium levels result in changes in neuronal morphology through immediate lo-
cal mechanisms and more prolonged mechanisms acting on the transcriptional level. 
fast local responses are mediated by calcium sensitive signalling proteins and result 
in restructuring of the dendritic cytoskeleton, affecting spine dynamics and formation, 
initiation of filopodia, branch stability and local translation. (maletic-savatic, et al. 
1999; sutton, et al. 2004; Wong and ghosh, 2002; Wu, et al. 2001). strict temporal 
regulation of calcium signalling and its downstream components has been suggested 
to have an important role in the developmental program (gruol, et al. 2006). time-de-
pendent changes in intracellular ca2+ concentrations are important regulators of syn-
apse formation (Berridge, et al. 2000; crabtree, 2001). in neuronal growth cones, ca2+ 
waves are spatially and temporally highly regulated during growth-cone turning, and 
their elimination inhibits normal neuronal differentiation. ca2+ links external stimuli 
to internal processes such as growth-cone protrusion, axonal path finding and initial 
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formation of synaptic contacts (gomez and spitzer, 1999; gomez, et al. 2001; spitzer, 
et al. 2000). the ion channels that regulate these processes in the developing brain 
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are poorly characterized. the best characterized are mammalian transient receptor 
potential cation channels (trpcs) (minke, 2006). the trpc family comprises seven 
different plasma membrane channels (trpc1–trpc7) (minke, 2006; pedersen, et al. 
2005) of which trpc family member 5 (trpc5) is important in controlling neurite 
extension and growth cone morphology. it is a part of a larger precursor active zone 
complex and travel to the forming synapse in cytoplasmic transport packets together 
with other developmentally regulated proteins (greka, et al. 2003).
2.3.2 Calcium binding proteins and neuronal identity 
specific sub-populations of neurons in the cns can be identified by calcium binding 
proteins they express. differential distribution reflects specific functional character-
istics of different calcium binding proteins and also needs of different neuron types 
(Baimbridge, et al. 1992). the calcium binding proteins have varied affinities and ki-
netics. the best characterized family includes calbindin d-28K/calbindin1, calretinin 
and parvalbumin, that have structural similarities the first two having fast kinetics and 
the latter slow kinetics respectively (lee, 2001; schwaller, et al. 2002). expression 
of these proteins has a strong developmental correlation: calbindin d-28K/calbindin1 
appears at the same time in developing neurons as voltage-gated calcium channels 
start to emerge and calretinin expression is temporally correlated with the onset of 
synaptic inputs respectively (hack, et al. 2000). expression of both proteins is also 
parallel to maturation in neuronal circuits (alcantara, et al. 1996; schierle, et al. 1997; 
schlosser, et al. 1999). parvalbumin in contrast is expressed highly in later stages 
(Baimbridge, et al. 1992; hof, et al. 1999). the developmental significance of these 
proteins is thought to also be manifested through their neuroprotective actions. espe-
cially calbindin d-28K/calbindin1 expression protects cells from activity dependent 
glutamate induced perturbations in calcium homeostasis (mattson, et al. 1991). in 
addition to developmental significance calcium binding proteins are central in main-
tenance of calcium homeostasis in mature neuronal function. the dependence be-
tween calcium binding proteins and calcium itself is thought to be two-way: changes 
in calbindin d-28K/calbindin1 expression alter calcium homeostasis (lledo, et al. 
1992). changes in calcium concentration, such as chelation of extracellular calcium, 
and blocking of voltage-operated calcium channels, inhibit upregulation of expression 
(Boukhaddaoui, et al. 2000).
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2.3.3 Regulating intracellular calcium levels
neurons have many mechanisms to regulate their calcium in addition to direct free 
calcium binding. the neuronal calcium release/flow into the cytoplasm is regulated 
through the plasma membrane and intracellular membrane responses. on the plasma 
membrane ca2+ channels in different parts of the cell carry out separate functions. n- 
and p/Q-type voltage gated or voltage operated calcium channels (vocs) are located 
at axonal synaptic endings and trigger the release of neurotransmitters. the l-type 
vocs on the cell body and proximal dendrites supply the ca2+ signals for inducing 
gene activation and transcriptional modulation and respond to the small depolariza-
tions at synaptic spines (evans and Zamponi, 2006; mermelstein, et al. 2000). the 
ca2+ signals in spines are also responsible for mediating the early synaptic modifica-
tions important in learning and memory. they are mediated by calcium entry through 
vocs and receptor operated channels (such as nmda (n-methyl-d-aspartate) recep-
tors) and by release from internal stores through channels such as inositol-1,4,5-tri-
sphosphate receptors (insp3r) or ryanodine receptors (rYr) (reviewed in Berridge 
1998). in memory and learning the role of insp3rs is correlation of pre- and postsy-
naptic inputs through coincidence detection. insp3 receptors respond to ca2+ flowing 
through vocs in response to membrane depolarization and simultaneous appearance 
of ins(1,4,5)p 3 produced by metabotropic glutamate receptors (mglur1). the result 
is synergistic release of calcium from the er internal stores (choe and ehrlich, 2006). 
insp3rs and ryanodine receptors are also central in ca2+-induced ca2+ release in which 
cytoplasmic ca2+ activates the release of ca2+ from internal stores through an autocata-
lytic mechanism. furthermore, calcium controls the transcription of its own transport-
ers and channels in different domains of developing neurons (carafoli, et al. 1999). 
2.3.4  Organelles involved in the maintenance  
of calcium homeostasis
high calcium concentration is toxic to neurons, it has to be removed rapidly after it 
has completed its signalling functions. for this cells have several mechanisms: ion 
pumps and exchangers remove excess ca2+ and it is also sequestered into the mi-
tochondria and other cellular organelles (michelangeli, et al. 2005; prinsen, et al. 
2002; Uehara, et al. 2005). the plasma membrane ca2+-atpase (pmca) pumps and 
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na+/ca2+ exchangers extrude ca2+ to the outside and the sarco-endoplasmic reticulum 
atpase (serca) pumps return ca2+ to the internal stores.
another key component in calcium metabolism is the mitochondrion. it sequesters 
calcium rapidly and has a high accumulation capacity while the mitochondrial matrix 
contains buffers that efficiently prevent excess calcium build-up. the mitochondria 
sequester ca2+ utilizing the mitochondrial ca2+ uniporter (mcU) located on the inner 
mitochondrial membrane (Bernardi, 1999; gunter, et al. 2004). mitochondria extrude 
protons to create the electrochemical gradient necessary for atp synthesis and this 
gradient is also used to drive ca2+ uptake through the mcU. the high levels of cy-
tosolic ca2+ needed to activate the mcU exist in localized micro-domains close to 
clusters of er or plasma membrane ca2+ channels and mitochondria accumulate ca2+ 
more effectively when they are close to ca2+-releasing channels (dyer, et al. 2003; 
rizzuto, et al. 1993; rizzuto, et al. 2004). mitochondria also regulate ion channels 
that open in response to binding of an extracellular ligand (so called store-operated 
ca2+ entry) (glitsch, et al. 2002). various proteins implicated in neurodegeneration, 
such as presenilins, and apoptosis regulatory proteins modulate mitochondria and er 
interplay and calcium handling. once the cytosolic ca2+ has returned to its resting 
level, the mitochondrion decreases its ca2+ concentration by pumping excess cal-
cium into the cytoplasm through the mitochondrial na+/ca2+ exchanger (nce) or the 
permeability transition pore (ptp) (Bernardi, 1999). the ptp also contributes to the 
initiation of apoptosis during the occurrence of irreversibly high ca2+ concentrations: 
it collapses the transmembrane potential that leads to the release of cyctochrome c and 
activation of the apoptotic cascade (szabadkai and rizzuto, 2004).
in addition to er and mitochondria the nuclear envelope, golgi and lysosome related 
organelles have been implicated in maintenance of cellular ca2+ homeostasis (michelan-
geli, et al. 2005).  invaginations of the nuclear envelope of certain cell types contain 
insp3rs, rYrs and serca pumps and lumenal space that can act as a ca2+ store 
(gerasimenko, et al. 2003; humber, et al. 1996; Xu, et al. 2001). the golgi compartment 
also contains insp3rs (surra and Wolff, 2000) and two types of ca2+ pumps, the ‘clas-
sical’ serca type and the secretory pathway ca2+ atpase (spca), that is exclusively 
expressed in the golgi (Wootton, et al. 2004). also the lysosome and late endosomes 
have ca2+ regulatory functions. they contain nicotinic acid dinucleotide phosphate 
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(naadp) operated calcium channels and h+–ca2+ exchangers (hce). a trpc related 
ca2+ channel mucolipin-1 has also been identified on lysosomes and late endosomes, 
and has been implicated in lysosome biogenesis (piper and luzio, 2004).
2.4 Cholesterol metabolism in the developing brain
cholesterol is a key component of cellular membranes and regulates a variety of cel-
lular functions. most mammalian cells are able to synthesize cholesterol and also 
receive it from external sources. this process is highly regulated through feedback 
control in order to maintain the correct sterol balance prerequisite to proper cellular 
function. cells synthesize cholesterol from acetyl coa through a series of over 20 
enzymatic reactions. 3-hydroxy-3-methylglutaryl coenzyme a (hmg coa) synthase 
and hmg coa reductase are rate-limiting enzymes of the biosynthetic pathway and 
their activity is sharply reduced in response to external cholesterol input via the low-
density lipoprotein (ldl) pathway. once cholesterol is depleted from the extracellular 
milieu large numbers of ldl receptors are inserted on the plasma membrane. (sato 
and takano, 1995). external cholesterol is obtained from plasma via the classical 
route in which ldl particles, that are internalized in clathrin-coated pits via the ldl 
receptor mediated pathway, are hydrolyzed to free cholesterol in the lysosomes. also 
alternative routes of uptake may be employed in which free cholesterol or cholesterol 
esters from lipoproteins are internalized on the cell surface, without endocytic uptake 
of the particle. (azhar, et al. 1999). in the late endocytic organelles, free cholesterol 
is mobilized to other cellular membranes and this process requires the niemann-pick 
type c1 (npc-1) protein. this membrane protein of the late endosomal/lysosomal 
membrane, defective in the niemann-pick disease type c, has been suggested to func-
tion as a regulator of cholesterol efflux from late endocytic organelles. however, the 
exact molecular function of the npc-1 protein is still unclear (Kuwabara and labou-
esse, 2002; patterson, 2003).
the brain is enriched in cholesterol, the cholesterol concentration being up to ten 
times higher, compared to other organs (dietschy and turley, 2004). cholesterol me-
tabolism in the brain is segregated from other tissues because the cns is isolated 
from the plasma by the blood–brain barrier that restricts the movement of plasma 
lipoproteins into the brain (turley, et al. 1998). therefore essentially all cholesterol is 
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synthesized within the brain. in the brain cholesterol is abundant in oligodendrocytes 
since the myelin sheath that they from contains 70–80% of total cholesterol (dietschy 
and turley, 2004). during brain development, oligodendrocytes wrap their plasma 
membrane around axons to produce the myelin sheath. it is a specialized membrane 
structure highly enriched in galactosylceramide (galc) and cholesterol and arranged 
by the main proteinaceous component the myelin basic protein (mBp). it is the neuro-
nal cells that induce the lipid condensation of the oligodendroglial membrane, during 
myelin formation. mBp is a essential part of this plasma membrane rearrangement, 
since the clustering is not observed in shiverer mice that lack mBp (fitzner, et al. 
2006). the rate of cholesterol synthesis in the cns is highest in the developing brain, 
during the active myelination phase. this synthesis decreases upon maturation but 
cholesterol synthesis continues in the adult brain since also other cell types in the 
cns, the astrocytes and neurons, require cholesterol for proper cellular function (di-
etschy and turley, 2004; spady and dietschy, 1983). the brain has an independent 
lipoprotein transport system in which glial cells produce apoe (apolipoprotein e)-
containing lipoproteins. apoe is a component of lipoproteins that also contain choles-
terol and phospholipids (ladu, et al. 2000; pitas, et al.  1987). the glia derived apoe 
associated lipoprotein particles convey cholesterol to neurons for axonal growth and 
repair functions. defects in cholesterol homeostasis in the brain have been associated 
with development of several neurological disorders, including alzheimer’s disease 
and npc (reviewed in vance, et al. 2005). even though apoe-containing lipoproteins 
produced by glial cells are normal in npc, due to the cholesterol efflux regulation de-
fect, cholesterol accumulates in somatic areas of neurons and the cholesterol content 
of axons is in contrast reduced. this results in defects in neuronal function, possibly in 
the recycling of synaptic vesicles (vance, et al. 2006). apoe-binding receptors partici-
pate in cholesterol uptake, and furthermore these receptors are required for signalling 
pathways in neurons during development (trommsdorff, et al. 1999). 
2.5 Cell death mechanims in neurons
death of neurons occurs as a normal physiological process during development and 
as a pathological process in disease and injury. neuronal death occurs by at least three 
different mechanisms: apoptosis, autophagy and necrosis. according to the current 
understanding these mechanisms share at least some overlapping regulators and fea-
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tures. apoptosis is central in neuronal death during development. it is characterized by 
morphological features such as dna fragmentation, cytoskeletal collapse and mem-
brane blebbing and also by activation of cellular pathways including the caspase (fam-
ily of cysteine proteases) cascade, aided by adaptor proteins and mitochondria linked 
pathways mediated by the Bcl-2 family proteins (Yuan and Yanker, 2000; chang and 
reynolds, 2006). the second mechanism of cell death, autophagy, is also character-
ized by similar morphological features as apoptosis and in addition by the appearance 
of lysosome originated autophagic vacuoles and intracellular organelle swelling.  the 
molecular mechanims regulating autophagy in neurons are still poorly understood but 
potential contributors include the pi3K pathway and the caspases (guillon-munos 
and van Bemmelen, 2005). autophagy is a central housekeeping mechanism regulat-
ing turnover of intracellular organelles and some long-lived proteins but has also been 
implicated in neurodegenerative diseases (he and Klionsky 2006). necrotic cell death 
is characterized by swelling and disruption of membrane integrity and distinguished 
from the other two types by the lack of lysosome as well as caspase involvement 
(Yuan, et al. 2003).
3. Cell biology of lysosomal storage disorders
3.1 Lysosomal storage disorders
studying disease and pathophysiological mechanisms behind them provides infor-
mation on disease mechanisms and in many cases normal cell physiology. good ex-
amples of this principle are the lysosomal storage disorders (lsds). lysosomes are 
cellular organelles that are responsible for the degradation of various cellular me-
tabolites. they are composed of a limiting external membrane containing intra-lumi-
nal vesicles. the lysosomes are estimated to contain 50-60 soluble acidic hydrolases 
(Journet, et al. 2002), 215 integral membrane proteins and 55 membrane associated 
proteins (Bagshaw, et al. 2005). dysfunction in any of these components may cause 
lysosomal dysfunction leading to accumulation of undegraded metabolites and ulti-
mately disease. lysosomal storage disorders are often characterized according to the 
accumulating material or the defective protein. these comprise the sphingolipidoses, 
mucopolysaccharidoses, oligosaccharidoses and glycoproteinoses, lipidoses, diseases 
where the defective protein is an integral membrane protein and others. over 40 lyso-
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somal storage disorders (lsds) that involve soluble hydrolases are known (futerman 
and van meer, 2004). the first lsds were described already in the late nineteenth 
century; however, typically the molecular basis of the lsds remained unclear until 
arrival of modern techniques. even now when the genetic, molecular and biochemical 
background of many lsds are understood, little is known about how accumulation 
of specific material to the lysosomes causes disease at the cellular level (futerman 
and van meer, 2004). furthermore, questions remain open on the exact nature of the 
defect when accumulating material does not have an apparent relation to the defective 
enzyme as is the case with the topic of this thesis, the ncl group diseases. 
3.2 Lysosomal storage and cellular function
how do cells maintain or lose their function in response to lysosomal storage? several 
different strategies have been suggested ranging from general cellular responses to 
activation of disease specific mechanisms. individuals affected by lsds have in most 
cases lysosomal accumulation in all cell types. While the same defect is present in all 
cells, not all cell types become affected. most lsds have pronounced cns manifes-
tation but peripheral cells remain relatively unaffected. examples include sphingoli-
pidoses, lipidoses, glucoproteinoses and the ncl disorders (futerman and van meer, 
2004; mole, et al. 2005). neurons seem particularly vulnerable to lysosomal storage 
but the exact reason for this is still unclear. the vulnerability may partly be caused 
by limited cell regeneration potential in the cns and also by lack of compensatory 
cellular metabolic pathways (futerman and van meer, 2004; tardy, et al. 2004). for 
most lsds, the pathology mainly involves neuronal dysfunction rather than loss. the 
main exceptions to this are niemann–pick disease type c (npc), in which differential 
loss of purkinje neurons takes place, and the neuronal ceroid lipofuscinoses (ncls) 
that are characterized by a massive neuronal loss at the cortex (santavuori, et al. 1973; 
Walkley and suzuki, 2004).
it has been suggested that accumulation of undegraded substrates in lysosomes leads 
to a intra-lysosomal protein response similar to which is seen in the er in response to 
accumulation of unfolded proteins where several cellular pathways are activated lead-
ing to transcriptional changes and upregulation of degradative systems (see Zhang 
and Kaufman, 2006 for review). it is also possible that the aggregations in the lyso-
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somes themselves are not pathogenic to the cells but rather diffuse mutant proteins in 
the cytosol (arrasate, et al. 2004; Bjorkoy, et al. 2005; tanaka, et al. 2004; taylor, et 
al. 2003). in this case autophagic systems would be activated. autophagy is a rather 
non-selective process in which cellular components are dergaded in the lysosomes. in 
the autophagy event small parts of the cytoplasm are sequestered into autophagosome 
vesicles which then fuse with the lysosomes and the contents is degraded (Klionsky, 
2005; levine and Klionsky, 2004). autophagy mediated protein quality control is 
especially important in neural cells and impairment of autophagy can contribute to 
and even worsen the accumulation in neurodegenerative diseases (fortun, et al. 2003; 
ravikumar, et al. 2002). activation of autophagy might facilitate the removal of in-
tracellular protein aggregates (Jellinger and stadelmann, 2000; larsen and sulzer, 
2002). autophagy has been shown to be involved in the abnormal storage accumula-
tion in lysosomal storage disorders, including ncl (cao, et al. 2006; Koike, et al. 
2005; tardy, et al. 2004).
???????????????????? ???????? ? ? ??????????? ? ????????????? ?????????????????????????????????????????????
??????? ? ? ? ? ? ? ? ? ? ? ? ???????? ?
?????????????????? ???????????????? ? ??????????????????? ????????????????? ?????????????????????
?????????????????? ? ? ? ????????????????????? ????????????????? ? ??
? ? ? ??????????????????? ???????????????? ? ????????????????? ? ??
? ? ? ?????????????????? ??????????????????? ??????????????????????????? ??
? ? ? ????????????????? ? ????????????????????? ??????????????????????????? ??
? ? ? ?????????????? ? ?????????????????? ????????????????????? ? ???
? ? ? ?????????????? ??? ????????????????? ?????????????? ? ? ??
??????????????????????? ?????????????????????? ????????????????????? ?????????????????????????? ?
?????????????????? ? ? ? ??????????????????????
????????????????????? ?????????????????? ? ???????????????????? ??????????????????????????????? ????????????????????
?????????????????? ? ? ? ???????????
? ? ? ? ? ? ????????????????
? ? ? ? ? ? ????????????????
???????????????????????? ?????????????????????? ?????????????????????? ????????????????????????????????????????????????
???????????????????? ??????????? ?
?????????? ? ??????????????????????? ??????????????????????? ???????????? ? ? ??
? ? ? ??????????????????? ???????
? ? ? ??????????????????? ????? ? ? ????????????? ?????????????
? ? ? ? ? ? ? ? ? ????????????
???????????????? ?????????????? ? ????????????? ? ????????????????????????????
???????? ? ? ????????????? ? ????? ? ? ????????????? ?????????????
? ? ? ? ? ? ? ? ? ????????????
? ? ? ?????????????? ? ??????? ? ? ???????????
??????? ? ? ?????????????????? ????????????????? ? ???????????
? ? ? ? ? ? ?????
? ? ? ?????????????? ? ????? ? ? ??????????????????????
? ? ? ? ? ? ? ? ? ????????????????
? ? ? ?????????????? ? ?????????????? ? ????????? ? ?????? ????????????????
? ? ? ? ? ? ? ? ? ? ? ? ?????? ? ??????????????
Table 1. Lysosomal Storage disorders classified according to molecular defect and storage material
Adapted from: Jeyakumar et al. 2005; Futerman and van Meer 2004   
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even when unmetabolized substrates remain the primary cause of lysosomal storage 
disease and while general responses to accumulations in the lysosomes or cytosolic 
misfolded proteins may play a role in disease pathology, the wide range of disease 
symptoms in lsds indicates that a plethora of secondary and even tertiary cellular 
and biochemical pathways are also activated.  moreover, many lsds are character-
ized by phenotypic variability: phenotype cannot be predicted on the basis of the 
gene defect or even accumulating substance. patients with similar genetic background 
show variable clinical symptoms presumably due to modifying genes and environ-
mental factors (futerman and van meer, 2004). the possible pathways from primary 
defect to pathology are presented in figure 5.
Gene defect leads to
accumulation on
metabolites in lysosomes
Primary cause of a LSD Secondary cause Downstream pathways affected
Tertiary cellular
pathways
Tissue pathology
Cell/tissue
damage
and death
Modifying genes 
Environmental factors
Changes in cellular
processes
Secondary cellular
pathways
Altered gene
expression
Figure 5. Pathways to Pathology in Lysosomal Storage Diseases.
3.3 Mechanims of lysosomal pathology
the pathogenic cascades resulting from lysosomal storage in many lsds have been 
shown to share pathological features with common neurodegenerative diseases. these 
include altered calcium homeostasis, altered endosomal/lysosomal function and in-
flammation in the cns. (Jeyakumar, et al. 2005). altered calcium homeostasis has 
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been described in several lsds, including the glycosphingolipid (gsl) storage dis-
order gaucher’s disease (Korkotian, et al. 1999; lloyd-evans, et al. 2003) and the 
ganglioside storage disorder sandhoff’s disease (pelled, et al. 2003). in the gaucher 
mice cells, an er calcium channel agonist, the ryanodine reseptor, induced enhanced 
calcium release from the er internal stores. in addition, increased sensitivity to gluta-
mate-mediated neurotoxicity, was present. a calcium-related phenotype was identi-
fied also in the mouse model of sandhoff disease. in this model a profound reduction 
in the rate of calcium uptake but no difference in the rate of calcium release from the 
er, was observed. this defect was attributed to modulation of the sarcoendoplasmic 
reticulum calcium atpase (serca) by the storage ganglioside gm2.
altered endosomal/lysosomal function contributes to pathology in lsds and defects 
have been demonstrated in various steps of endosomal trafficking. altered trafficking 
of sphingolipids, connected to either elevated cholesterol levels or altered cholesterol 
distribution occurs in several storage disorders (chen, et al. 1999; reviewed in olk-
konen and ikonen, 2006). defective trafficking due to failure in correct production 
or recognition of endocytic sorting signal is present in some lsds: examples include 
mucolipidosis ii (i-cell disease) and related milder disorders. i-cell disease is cause 
by impaired activity of the n-acetylglucosamine-1-phosphotransferase enzyme. this 
results in missorting of multiple lysosomal hydrolases, causing leakage of these pro-
teins from cells and deposits of undegraded material (glickman and Kornfeld, 1993; 
varki, et al. 1981). this enzyme catalyses the addition of mannose 6-phosphate (m6p) 
on lysosomal proteins, that are recognized in the trans-golgi network (tgn) or at the 
cell surface by m6p receptors (mprs) and routed to lysosomes. additionally, defects 
in	mucolipidosis	II	and	IIIA	were	recently	pinpointed	to	the	gene	encoding	the	α	and	
ß subunits of this enzyme (Kudo, et al. 2006; raas-rothschild, et al. 2004; tiede, et 
al. 2005). trafficking defects, characterized as delay in several endocytic pathways, 
have been described in ncl group of diseases (heine, et al. 2004; luiro, et al. 2004). 
trafficking defects have also been suggested to contribute specifically to the neuropa-
thology of lsds. for example in normal neurons, the late endosomal/lysosomal com-
partment is primarily confined to the soma, however in cultured neurons lysosomes 
have also been reported in the axon (overly and hollenbeck, 1996). the lysosomes 
in the axon can potentially fuse with endosomes derived from synaptic areas, and it 
has been suggested that some degradative events might occur already while these 
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organelles travel to the cell body. the lysosomal storage in lsds might cause de-
fects in the retrograde transport of lysosomes, possibly by preventing the acidification 
of endosomes derived from the axon terminal. alternatively retrograde transport of 
components along the axon might be impaired by storage in the cell body. abnormal 
synaptic function has been shown in gangliosidoses and implied in npc (Karabelas 
and Walkley, 1985; Karten, et al. 2006; Walkley and suzuki, 2004).
abnormal inflammatory responses in the brain are common in lsds. they are present 
in glycosphingolipidoses, the gangliosidosis sandhoff disease and in all types of 
ncls (cooper, et al. 2006; Jeyakumar, et al. 2005). astrocytosis and microglial acti-
vation are found in several ncls in patient autopsy material as well as mouse models 
(cooper, et al. 2006; mitchison, et al. 2004; pontikis, et al. 2004).
4. Infantile neuronal ceroid lipofuscinosis
4.1 Neuronal ceroid lipofuscinoses
the neuronal ceroid lipofuscinoses (ncls) are a group of autosomal, recessively in-
herited, neurodegenerative diseases with an onset usually in the childhood. at least 
ten different ncl diseases classified according to the gene defect, varying in severity, 
have been described. to date approximately 160 ncl causing mutations have been 
found in seven human genes (CLN1, CLN2, CLN3, CLN5, CLN6, CLN7, CLN8 and 
CLN10, http://www.ucl.ac.uk/ncl) of which CLN7 and CLN10/CTSD are the new-
est (a. lehesjoki et al., unpublished; siintola, et al. 2006; steinfeld, et al. 2006). at 
least two more ncl genes, CLN4 and CLN9, are anticipated to exist. in table 2 are 
presented the human ncl genes, associated clinical phenotype and storage material. 
despite being a genetically heterogeneous group, the ncls share morphological as 
well as histopathological and clinical characteristics. two most essential findings in 
all ncls are loss of neurons in the central nervous system mainly in the cerebral and 
cerebellar cortices and accumulation of autofluorescent material, so called ceroid-li-
popigments, in most tissues (goebel, et al. 1999). clinically, the ncls are marked by 
several symptoms caused by the neurodegeneration commencing with visual impair-
ment leading to blindness, sleep problems, motor abnormalities, epilepsia, dementia 
and eventually premature death (santavuori, et al. 2000). While the disease phenotype 
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is quite constant across the childhood ncls, precluding CLN8 or northern epilepsy, 
the age of onset and course of the disease varies. the ncls were originally classi-
fied based on the clinical onset of symptoms to four main forms: infantile (incl), 
late-infantile (lincl), juvenile (Jncl) and adult forms (ancl;cln4, gene not 
identified). in recent years several so-called variant forms have been recognised hav-
ing later onset than the classical forms or being less severe or protracted in course 
(goebel, et al. 1999; mole, et al. 2005).  the ncls occur worldwide and are consid-
ered most common progressive brain disorders in children (haltia, 2003; mole, et al. 
2005). they are especially common in finland, the most common types being incl 
(incidence 1:20 000) and Jncl (incidence 1:21 000). the classic late infantile form 
ncl (lincl) is rare, whereas the finnish variant lincl (vlinclfin) is more com-
mon (santavuori, 1988).
Gene Protein   Type   Main storage protein Ultrastructure Clinical phenotype
CLN1 PPT1 , palmitoyl Soluble lysosomal & Saposin A & D GROD INCL , also LINCL 
protein thioesterase 1 neuronal extensions      and ANCL
CLN2 TPP1 , tripeptidyl Soluble lysosomal SCMAS   CL LINCL, also JNCL
peptidase
CLN3 CLN3   Transmembrane SCMAS   FP (CL, RL) JNCL
CLN4 not known        FP, granular ANCL
CLN5 CLN5   Soluble lysosomal/ SCMAS & RL, CL, FP LINCL,  also Finnish
   transmembrane Saposin A & D    variant and JNCL
CLN6 CLN6 Transmembrane, SCMAS   RL, CL, FP LINCL , also EJNCL
    ER resident       Indian/Costa Rican/
            Czech Gypsy variant,
            JNCL
CLN7 unpublished unpublished SCMAS   RL, CL, FP LINCL , Turkish variant
CLN8 CLN8   Transmembrane, SCMAS   CL-like granular Northern epilepsy,
    ER resident       also Turkish variant,
           JNCL
CLN9 unpublished
CLN10  CTSD   Soluble lysosomal Saposin A & D GROD, FP congenital NCL
cathepsin D
Table 2. T he neuronal ceroid lipofuscinoses
Classification of the neuronal ceroid lipofuscinoses. Genes and respective proteins, main storage protein, ultrastructural 
phenotypes of storage bodies and clinical phenotypes are presented.
Saposin, sphingolipid activator protein; SCMAS, subunit c of mitochondrial ATP synthase; GROD, granular osmiophilic
deposits; CL, curvilinear profiles; FP, fingerprint bodies; RL, rectilinear complexes
(Vesa et al. 1995; Sharp et al. 1997; Sleat et al. 1997; Järvelä et al. 1998; International Batten Disease Consortium. 1995;
Berkovic et al. 1988; Savukoski et al. 1998; Wheeler et al.1999; Ranta et al. 1997; Schulz et al.  2006;  Siintola et al.2006)
ncls are considered as lysosomal diseases and have some properties that group them 
with the classical lysosomal storage diseases (lsds), however also many distinctive 
characteristics are observed. in ncls the ceroid-lipopigments are accumulated in the 
lysosomes. the diseases have a spectrum of severity being present in the infantile, 
juvenile and adult forms, the most severe infantile form having cns symptoms and 
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whereas in the adult form peripheral symptoms predominate. the ncl disorders are 
recessively inherited and many of the ncl proteins are present in the lysosomes. 
these are characteristics of many lsds (futerman and van meer, 2004). the ncls 
cannot, however, be treated as classical lsds, such as sphingolipidoses and muco-
polysaccharidoses, where enzyme or transporter deficiency/dysfunction leads to ac-
cumulation of the specific undergraded metabolites in lysosomes. the accumulating 
material in ncls is not a disease specific substrate. the main accumulating material 
in all ncls except incl and concl is the subunit c of mitochondrial atp synthase 
which is present in other lsds as well as the main storage proteins sphingolipid acti-
vator proteins a and d in incl and concl. also the intracellular localization of at 
least two ncl proteins is not in the lysosomes but neuronal extensions.
4.2 Clinical and neuropathological findings in INCL patients
infantile neuronal ceroid lipofuscinosis (incl) (mim 256730) is caused by muta-
tions in the CLN1 gene, residing on chromosome 1p32, encoding palmitoyl protein 
thioesterase 1 (ppt1, ec 3.1.2.22) (Järvelä, et al. 1991; vesa, et al. 1995). incl is the 
most severe of ncl types. the clinical spectrum is wide depending on the mutation 
of the CLN1 gene, ranging from infancy to adulthood. 
the infantile onset form predominates in finland. incl children develop quite nor-
mally for the first year of life but development starts to slow down during the second 
year. first symptoms start at the age of 10-18 months and are followed by slowing 
down of development, visual failure and epileptic seizures (santavuori, et al. 2000). 
symptoms such as restlessness and sleep problems are thought to be of thalamic 
origin since magnetic resonance imaging (mri) and electroencephalography (eeg) 
findings indicate thalamic dysfunction (vanhanen, et al. 1994; vanhanen, et al. 1995). 
retinas show progressive deterioration as seen by electroretinography (erg) find-
ings (vanhanen, et al. 1997). loss of neurons is observed in most parts of the brain, 
however the extent of neuronal loss varies. the cerebral cortex is almost totally lost 
and the cerebellum is also atrophied whereas the brain stem and spinal cord appear 
almost normal. consistently with the observed visual impairment the optic nerves are 
severely atrophic and the myelin sheaths are replaced by glial tissues (tarkkanen, et 
al. 1977). clustering of glial cells filled with the storage material is present in all brain 
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areas (haltia, et al. 1973). eeg inactivity, indicating total loss of cortical function, is 
also seen from three years onwards (santavuori, et al. 1973). patients have low gaBa 
concentrations in their cerebrospinal fluid (csf) (santavuori, et al. 1993). premature 
death follows not until ages between 9 and 11 years, mainly due to neurodegeneration 
being present mainly in the cerebral and cerebellar cortices leaving the brain stem 
almost intact.  
4.3 Intracellular ceroid-lipofuscin storage in INCL
most cell types of incl patients accumulate membrane bound storage deposits, 
called granular osmiophilic deposits (grods). these deposits are disease specific. 
they are always present in a disease caused by mutations in the CLN1 gene and have 
a similar ultrastructure independent from the clinical subtype (van diggelen, et al. 
2001). the deposits reside in the lysosomes and resemble autofluorescent lipofuscin 
pigments that accumulate in cells during normal aging. however, grods can be dif-
ferentiated from normal aging pigment by virtue of lipid droplets they contain (lu, 
et al. 1996; tyynelä, et al. 1993). grods have a packed globular structure which is 
more granular and tightly packed in neurons and coarser and looser in non-neuronal 
cells. grods can be detected for diagnostic purposes in blood lymphocytes and skin 
dermal cell types (mole, et al. 2005). granular lipopigments appear in mural cells of 
chorionic vessels after the 8th week of gestation, but the time of appearance in non-
chorionic fetal tissue is currently unknown (Wisniewski, et al. 1998).
major part of the storage material comprises of two sphingolipid activator proteins 
saposins a and d. saposins are small glycoproteins that promote the degradation of 
sphingolipids (fürst, et al. 1988). the normal lysosomal function of saposins is to ac-
tivate lysosomal hydrolases involved in glycosphingolipid degradation. the saposins 
are extremely hydrophobic and associate with the lysosomal membrane. due to this 
hydrophobicity the saposins have a tendency to self-aggregate. in most lysosomal 
storage diseases the levels of saposins are near normal (morimoto, et al. 1990). how-
ever, accumulation of various saposin species has been shown in some lysosomal 
storage diseases namely tay sachs, sandhoff, niemann-pick and gaucher disease. 
typical for incl is the specific massive accumulation of saposins a and d but not 
the other saposin species (tyynelä, et al. 1993). incl cells also show some lipid 
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accumulation leading to dramatic changes in the phospholipid molecular species of 
incl brains (Käkelä, et al. 2003). in contrast to the other ncl disorders as well as 
several other lysosomal storage disorders, incl cells do not accumulate the subunit c 
of the mitochondrial atp synthase (tyynelä, et al. 1993). the reason for saposin ac-
cumulation in incl is still unclear. however, abnormal saposin processing connected 
to defects in endocytosis, presented in this thesis work, may be the reason underlying 
the accumulation (ahtiainen, et al. 2006). further studies are still needed to unravel 
the mechanisms of neuronal death present in incl, to pinpoint the physiological role 
of the ppt1 enzyme and to clarify if storage is the reason or just the end result in the 
cascade leading to cell death.
4.4 Saposins, biosynthesis and pathway to lysosomes
sphingolipids and glycosphingolipids are components of the cellular membranes. 
membrane lipid content is dynamically regulated and sphingolipids are constitutively 
degraded in a process that takes place in intra-endosomal and -lysosomal compart-
ments. degradation requires water-soluble acid exohydrolases, anionic phospholipids 
and sphingolipid activator proteins such as the saps and gm2 activator proteins. 
sphingolipid activator proteins are proteins that have the ability to perturb the mem-
brane and bind lipids. they have specificities for different lipids and activating en-
zyme that catalyses the degradation (Kolter and sandhoff, 2005). the four mature 
saposin species a, B c and d are generated by cleavage from a common precursor 
prosaposin (prosap) (fürst and sandhoff, 1992; sandhoff and Kolter, 1997). the pro-
sap 65 kda precursor has two alternative trafficking routes: it is transported directly 
from the trans-golgi network (tgn) to the lysosomes via a mannose 6-phosphate 
(m6p) dependent pathway. the precursor can also traffic to lysosomes independently 
of m6p, in which case the precursor is modified into a 73 kda form and secreted. the 
secreted form is endocytosed back into the cell by receptor mediated endocytosis uti-
lizing the ldl receptor related protein (lrp) or m6p receptors and then transported 
via the endocytic pathway to the lysosomes. in the endo-lysosomal compartments 
prosap is proteolytically cleaved to four small polypeptides of 8–11 kda, known as 
saposins a–d (hiesberger, et al. 1998). the details of the cleavage process including 
the exact order of events and the compartment, in which it takes place, are still poorly 
characterized (vielhaber, et al. 1996).
42
4.5 PPT1 protein
4.5.1 Structure and function of PPT1
ppt1 is a depalmitoylating enzyme, which removes palmitate groups from s-acyl-
ated substrates in vitro (camp, et al. 1994). however, the specific in vivo substrate of 
the enzyme is unknown. the ppt1 polypeptide consists of 306 amino acids and has 
a signal sequence of 25 aa in the n-terminus that translocates the protein into the er 
lumen. ppt1 has three glycosylation sites and two sequence motifs that are character-
istic of thioesterases (schriner, et al. 1996). the crystal structure of the mature bovine 
ppt1 has been determined. it is 95% identical to the human ppt1. it is a monomeric 
globular	protein	and	 structure	has	a	α/β-hydrolase	 fold	with	 the	active	 site,	 a	 con-
served catalytic triad, composed of ser115-asp233-his289. proper glycosylation is 
required for stability and activity of the enzyme (Bellizzi, et al. 2000).
the exact physiological function and substrates of ppt1 have remained elusive. ppt1 
was originally characterized as a classical soluble lysosomal enzyme. in non-neuronal 
cells it is guided to the lysosome via the m6p receptor pathway as a typical lysosomal 
hydrolase (hellsten, et al. 1996; verkruyse and hofmann, 1996). ppt1 plays a role 
in the degradation of lipid-modified proteins, cleaving fatty acids (usually palmitate) 
from cysteine residues (lu, et al. 1996). eligible in vitro targets for ppt1 comprise 
proteins as well as peptides including the proto-oncoprotein h-ras, palmitoyl-coa 
and S-palmitoyl thioglucoside (camp, et al.  1994; van diggelen, et al. 1999). ppt1 
has also been shown to depalmitate several neuron-specific peptides, for example, 
gap-43 (growth-associated protein) and rhodopsin and reduce their membrane as-
sociation (cho, et al. 2000a; cho, et al. 2000b). 
4.5.2 PPT1 expression and intracellular localization
ppt1 is an abundant protein expressed in most tissues types. the highest expression 
is seen in spleen, brain, lung and testis (camp, et al. 1994; suopanki, et al. 1999). on 
whole tissue level in mouse and rat brains ppt1 expression varies depending on the 
developmental context. the expression increases during the maturation of the central 
nervous system reaching a peak level in early adulthood. ppt1 expression parallels 
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synaptogenesis events both spatially and temporally (isosomppi, et al. 1999; suo-
panki, et al. 1999). on the cellular level ppt1 has a differential intracellular distribu-
tion depending on the cell type. in non-neuronal cells ppt1 resides in the endolyso-
somal compartment and uses the classical m6p receptor-mediated pathway to reach 
the lysosomes (hellsten, et al. 1996; verkruyse and hofmann, 1996). in contrast, in 
neurons ppt1 is present in presynaptic regions of axons. more specifically it is en-
riched in synaptosomes and is associated also with the synaptic vesicles (heinonen, 
et al. 2000; lehtovirta, et al. 2001; ahtiainen et al. 2003) as shown by cell fractiona-
tion and cryoimmunoelectron microscopy studies. a similar differential distribution 
in neuronal and non-neuronal cells has also been reported for other proteins associated 
with neurodegenerative diseases such as presenilin (Kamal, et al. 2001) and another 
ncl protein cln3 (luiro, et al. 2001). 
5. Unravelling the INCL Disease Mechanism 
the exact disease mechanism in incl and the significance of lysosomal storage to 
disease pathology as well as reason for accumulation of the specific components in 
lysosomal storage in incl is still unclear. also the exact intracellular role of the ppt1 
protein and its significance in the neuronal physiological function are only beginning 
to be understood. a highly specific pattern of neuronal loss is present in the central 
nervous system and specific alterations in brain metabolites characterize the incl 
disease. extensive studies have been conducted both of patient tissues and various cell 
models as well as transgenic mouse models to characterize the sequence of cell loss 
and to understand the underlying molecular mechanisms in incl pathogenesis.
When studying a rare neurodegenerative disease a major obstacle is getting the mate-
rial for the research. even though non-invasive advanced functional imaging tech-
niques are emerging, studying cellular pathogenetic mechanisms and function at the 
molecular level necessitates the use of live cells. non-neuronal patient cells, such as 
the skin fibroblast cells, can be utilized. they are relatively easy and non-invasive to 
obtain, can be readily grown in culture and are amenable to various cell biological 
approaches. however, when studying a neurodegenerative disease the underlying de-
fect can have very different manifestations in different cell types. therefore it is also 
crucial to study the affected cells, in the case of incl the neurons. since central nerv-
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ous system neurons are relatively inaccessible, a genetically engineered experimental 
mouse disease model is an invaluable tool to study early pathogenic events and also 
universal mechanism of neuronal death and function. once landmarks for disease pro-
gression are established also therapeutic approaches and their efficacy can be tested.
5.1 Studies in patient tissues and cell models
Based on patient studies several mechanisms have been suggested to contribute to 
pathogenesis and ultimately death of neurons in incl. connections to energy me-
tabolism and calcium regulation are derived from studies by das and colleagues (das, 
et al. 1999) in incl patient fibroblasts. they have shown that basal atp synthase 
activity is reduced and regulation of the enzyme is absent in incl cells. activities of 
respiratory chain complexes ii and iv were also reduced. furthermore atp synthase 
was down-regulated under conditions of anoxia and was up-regulated in response to 
calcium. several studies have shown that the incl brain has alterations in the balance 
of various metabolites:  incl patient brains have decreased levels of N-acetylaspar-
tate (naa) and respectively proportional increase in myoinositol and lipids, decrease 
in	γ-aminobutyric	acid	(GABA),	glutamine	and	glutamate	(Sitter	et	al.	2004).	Patient	
brains also contain proportionally more phosphatidylcholine (pc), and less phosphati-
dylethanolamine (pe) and phosphatidylserine (ps). the incl cortex loses up to 65% 
of the normal phospholipid content, and the proportions of polyunsaturated molecular 
species decrease dramatically. furthermore, lysobisphosphatidic acid (lBpa, major 
component of the late endosomal membrane) is highly elevated in the incl brain 
(Käkelä, et al. 2003). it is highly probable that these changes alter signaling and mem-
brane trafficking in neurons contributing to disease pathology. 
tissue level studies on patients have revealed distinct patterns of neuronal degen-
eration. in the well studied hippocampus, the ca2-ca4 regions show degeneration 
whereas the ca1 region is relatively spared, characteristic specifically to ncls. 
typical patterns of astrocytosis and activated microglia are also present representing 
abnormal inflammatory responses. inhibitory interneurons show graded severity of 
loss with the relative sparing of calretinin-positive interneurons in all regions. the 
selective pattern of degeneration in interneuron populations has been suggested to 
associate with differential buffering capacities of cytosolic calcium-binding proteins. 
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(cooper, 2003; d’orlando, et al. 2002; haltia, et al. 2001). cell death mechanisms, 
neuronal apoptosis and the caspase cascade, have been studied in incl patient autop-
sy brain samples. apoptotic cell death in incl brain has been linked with low levels 
of insulin like growth factor-1 shortage (riikonen et al. 2000). neuronal apoptosis in 
incl brain has been shown to be caused by er stress mediated caspase-4 activation 
that leads to apoptosis via caspase-3. activated caspases 3 ja 4 were detected in the 
hippocampus and cortex as well as apoptosis markers poly-adp-ribose polymerase 
(parp) and X-box binding protein-1 (XBp1), a marker of er stress induced unfolded 
protein response. these results were functionally confirmed in lymphoblasts and pa-
tient fibroblasts. also abnormally high amounts of the palmitoylated protein gap-43, 
possibly contributing to er-stress, was detected in the brain (Kim, et al. 2006a). er 
stress induced reactive oxygen species increase and calcium homeostasis impairment 
leading to caspase-9 activation have also been implicated in rapid neurodegeneration 
in incl brain  (Kim, et al. 2006b).  
a range of cell level studies have been conducted in cell models. the role of ppt1 
in the metabolism of lipid-modified proteins was originally shown in metabolic la-
beling studies in patient incl fibroblast cells: lipophilic compounds, migrating as 
small peptides, were shown to be derived from a process of lysosomal degradation of 
lipid-modified proteins (lu, et al. 1996). the ph regulation has been studied in incl 
patient cells and the lysosomal ph has been shown to be elevated (holopainen, et al. 
2001). the interactions and common pathways of the different ncl proteins have 
also been characterized in patient cells. a recent cross correction study on apoptosis 
and cell growth, showed that ppt1 and the CLN2 protein tpp1, are to an extent inter-
changeable and they also were shown to co-immunoprecipitate (persaud-sawin, et al. 
2007). ppt1 expression has been shown to protect from cell death, whereas antisense 
ppt1 treatment induced apoptotic cell death in la-n-5 neuroblastoma cells (cho, et 
al. 2000a; cho, et al. 2000b).
5.2 Reproducing the disease, characterization 
of mouse models
to address the role of ppt1 in neurons as well as mechanisms leading to incl dis-
ease pathology genetically engineered disease model mice lacking ppt1, the murine 
46
counterpart of the human ppt1, have been produced: the Ppt1tm1Hof−/− mouse by gupta 
and colleagues (gupta, et al. 2001) and the Ppt1Deltaex4 mouse by Jalanko and col-
leagues published in 2005 (Jalanko, et al. 2005) and functionally characterized in 
this thesis work. (full descriptions of the ncl mouse models in the ncl mouse 
model database http://www.ucl.ac.uk/ncl-models/). the mice have pathology similar 
to the human incl disease. they accumulate autofluorescent grod storage mate-
rial, develop blindness, motor deficits and myoclonic seizures and die prematurely. 
thorough neuropathological characterization of the mouse models has also brought 
understanding of several novel features in ncl pathology. these include eye-opening 
findings about the nature of neurodegeneration in incl; the neuronal death is highly 
selective having a specific pattern and temporal course. also early events of the patho-
genesis are starting to be unveiled: the exact tissue pathology modelling has revealed 
the thalamic region central in early disease progression. (Bible, et al. 2004; cooper, 
et al. 2006; Kielar, et al. 2007) findings in patient brain autopsy samples, including 
the pattern of neuronal loss and abnormal inflammatory responses through early glial 
activation, are being recognized and further characterized in the mouse models.
neurodegeneration has been characterized in the ppt1-deficient mouse models with 
histological methods. the Ppt1Deltaex4 mouse shows severe reduction of brain weight 
and loss of gaBaergic interneurons in several brain areas, most prominently in the 
cortex and cerebellum, at the age of six months (Jalanko, et al. 2005). the neuropatho-
logical features of the Ppt1tm1Hof−/− mouse have been more widely characterized and 
the loss of gaBaergic interneurons is evident in this mouse model in the hippocam-
pus and cerebellum at the age of 6 moths (gupta, et al. 2001). interneuron populations 
exhibit a graded vulnerability dependent on location, and which calcium binding pro-
tein or neuropeptide(s) is expressed by subsets of these neurons. the mice show se-
vere loss of specific neuron populations: severe atrophy was observed in the primary 
visual and somatosensory barrel field with significant involvement of the lamina v 
pyramidal neurons and lamina iv granule neurons. the atrophy also involves subcor-
tical areas especially the thalamic region (Bible, et al. 2004). evidence in other ncl 
mouse models, namely the CLN3 mouse (pontikis, et al. 2004; Weimer, et al. 2006), 
suggests that changes in sensory cortex follow the loss of corresponding sensory relay 
neurons within the thalamus. therefore it seems that cellular location is the major 
determinant of neuron survival (cooper, et al. 2006). synaptic involvement in early 
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in disease pathogenesis has also been implicated. cultured neurons of the Ppt1tm1Hof−/− 
knock-out mice have a reduced synaptic vesicle pool size and the colocalization of 
ppt1 with presynaptic markers is lost by expression of mutant proteins (lehtovirta, et 
al. 2001; virmani, et al. 2005). 
the neuronal loss is in parallel with widespread astrocytic but more restricted micro-
glial activation. Upregulation of gfap, an astrocyte marker, expression has also been 
shown in microarray studies of ppt1-deficient mouse models (elshatory, et al. 2003). 
studies on the mechanisms of neuronal death in the Ppt1tm1Hof−/− knock-out mice have 
revealed morphological changes that have been correlated with er stress induced 
unfolded protein response similarly to incl patient brain autopsy samples. er stress 
induced apoptosis is mediated via the caspase cascade involving caspases 3 and 12 in 
mice (Zhang and Kaufman, 2006).
the mouse disease has recently been modeled in the context of efficiently charactering 
the outcome of treatment strategies. the gene therapy studies with an adeno-associ-
ated virus encoding ppt1 (aav2-ppt1), have shown improved histological and behav-
ioral parameters as well as decreased neurodegeneration through protective effects. 
Unfortunately, no significant improvement in the seizure phenotype or increased lon-
gevity could be shown. there are implications that the diffusion/trafficking properties 
of ppt1 differ from other lysosomal enzymes. therefore, these studies have empha-
sized the need for higher levels or a broader distribution of ppt1 expression for a more 
complete correction of the disease.  (griffey, et al. 2004; griffey, et al. 2006)
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Aims of the present study
this study was carried out to characterize the role of ppt1 in early neurodegenera-
tive events in incl. the impact of specific protein storage to pathogenesis and the 
relationship to ppt1 were also addressed. 
the specific aims of this study were the following:
•	 to determine the exact intracellular localization of ppt1 protein in neurons
•	 to analyse ppt1 expression during neuronal maturation in primary neuronal 
cultures
•	 to study intracellular trafficking pathways in ppt1 deficient patient cells
•	 to examine the role of lysosomal storage proteins, the saposins, in incl 
pathogenesis and the potential relationship between ppt1 and saposins
•	 to characterize functional properties of Ppt1Deltaex4 mouse neurons 
•	 to clarify mechanisms of early pathogenesis in incl utilizing Ppt1Deltaex4 
mouse neurons 
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Materials and methods
1. Published materials and methods
materials and methods used in this thesis are described in the original publications.
Table 3.
Material or Method Original publication
adenovirus -mediated gene expression I
assay for ppt1 activity I
fura-2 am ratiometric calcium imaging III
cloning of cdnas or other plasmid constructs I
confocal microscopy I, II, III
cholesterol biosynthesis in neuronal cultures III
dissection and culturing of primary retinal,  
cortical and hippocampal neurons I, II, III
dna extraction III
electron- and immunoelectron microscopy I
electrophysiological recordings  
by whole cell patch clamp method III
transcript profiling and data analysis III
immunofluorescence quantifications of confocal images II
immunoprecipitation II
mouse brain acute slice preparation I, II, III
metabolic labelling II
pharmacological agents affecting  
intracellular trafficking II
primary fibroblast cultures II
proliferation assay of neuronal stem cells III
protein detection by direct  
and indirect immunofluorescence I, II, III
protein detection by Western analysis II
receptor-mediated endocytosis assay II
non-receptor mediated endocytosis assay II
rna extraction III
semliki forest virus –mediated gene expression I
transferrin endocytosis and recycling assay II
transient transfections II
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2. Ethical aspects
this study has been evaluated and approved by the laboratory animal care and Use 
committee of the national public health institute, helsinki. this study has been con-
ducted following good practice in laboratory animal handling and according the regu-
lations for handling genetically modified organism.
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Results and discussion
1. Localization and expression of PPT1 
in neuronal synapses (I)
prior to this study the CLN1 gene defective in incl had been identified (vesa, et al. 
1995). intracellular localization and transport of the ppt1 protein had been pinpointed 
in non-neuronal cells (hellsten, et al. 1996; verkruyse, et al. 1996) and studies on neu-
ronal expression had been initiated. on tissue level ppt1 expression was shown to be 
developmentally regulated and coincide with synaptogenesis. (isosomppi, et al. 1999; 
suopanki, et al. 1999; heinonen, et al. 2000). main part of the incl disease symptoms 
arise from the neuronal dysfunction and ultimately degeneration whereas non-neuronal 
cell types remain, apart from storage material accumulation, relatively unaffected. Be-
cause of the severe neuronal manifestation ppt1 is postulated to have a crucial role in 
the development and survival of neurons. intracellular localization studies in neurons 
suggested presynaptic localization and accordingly it was anticipated that in neuronal 
cells ppt1 has extra-lysosomal functions, possibly associated with the development or 
maintenance of the synaptic machinery. therefore, it was of main importance to eluci-
date the exact intracellular location and expression patterns of ppt1 in normal neurons. 
in this study, neurons from the retina, hippocampus, and cortex were used because these 
cell types are most affected and ultimately lost in the course of incl disease. ppt1 ac-
tivity was measured during neuronal maturation in culture. Quantitative measurements 
of polarized protein expression in axons versus dendrites were performed and the intra-
cellular localization of endogenous and over expressed protein was studied.
1.1 Increase in PPT1 activity by neuronal maturation
to analyse the properties of ppt1, enzyme activity was monitored in primary mouse 
embryonic retinal and hippocampal neuron cultures at different maturation stages. 
measurements were made utilizing an artificial substrate, 4-methylumbelliferyl-6-
thiopalmitoyl-β-d-glucoside. this sensitive fluorogenic substrate is also used for pre- 
and postnatal enzyme analyses of incl (van diggelen, et al. 1999). samples from 
immature and mature cultures were studied. the measurements showed an overall 
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higher level of ppt1 activity in retinal neurons than in hippocampal neurons. how-
ever, the differences between groups did not reach statistical significance (p > 0.05) 
(i, fig. 1). activity measurements were made from primary neuron cultures, which 
often show heterogeneity explaining the relatively high variance within each group. 
furthermore, the higher level of expression of ppt1 in retinal neurons was verified by 
Western blot analysis (i, fig. 2a). 
a rise in ppt1 activity with time was observed in both cell types. especially in retinal 
neurons, a pronounced increase in ppt1 activity was detected in mature cultures at 13 
div. ppt1 preceded the expression of synaptophysin, a marker for mature synapses. 
the increase in activity of ppt1 also temporally coincided the increase in synapto-
physin expression, as detected by Western blot (i, fig. 2a). these results provided 
evidence that ppt1 activity associates with synaptic formation. these results also 
showed that ppt1 activity in neurons, especially in the retina, is under developmental 
regulation and that it increases with neuronal maturation.
1.2 PPT1 resides in axons in mature neurons
to analyse the exact intracellular distribution of ppt1 in neurons, localization of en-
dogenous and semliki forest virus (sfv) overexpressed ppt1 was studied by immun-
ofluorescence in neurons at different maturation stages. in immature embryonic cortical 
stage 2 neurons cultured for two days no endogenous ppt1 was yet detected (i, fig.3a). 
more mature stage 4 embryonic neurons, cultured for eight days, showed immunopo-
sitivity for endogenous ppt1 (red) that localizes mostly to map-2 negative axons (i, 
fig.3B).  in the postnatal neurons (postnatal day 1) cultured for 8 div, the map-2 
negative neurites were intensively labeled for ppt1 (i, fig. 3c). moreover, the ppt1 
positive puncta colocalized significantly well with axonal markers map-1 (i, fig. 3d) 
and gap-43 (i, fig. 3e). colocalization with gap-43 was seen especially in axonal 
varicosities but less in growth cones (i, fig. 3e). mature embryonic retinal neurons 
showed a similar distribution (i, fig. 3f). sfv overexpressed ppt1 distribution did not 
differ from the endogenous protein. in mature neurons the distribution of sfv-mediated 
human ppt1 colocalized with the presynaptic marker sv2 (i, fig. 4a). 
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the expression of ppt1 preceded that of the synaptic vesicle protein 2 and synapto-
physin, indicating that ppt1 has significance in the early development or maturation 
of neurons. to further specify the localization of ppt1 in axons, immunofluorescence 
analysis of ppt1 with the synaptic markers sv2 and synaptophysin was performed. 
immunofluorescence staining of 8 div retina showed the endogenous ppt1 and sv2 
distributed in the axonal varicosities (fig. 5a). endogenous ppt1 was detected in 
cortical neurons at a later time compared to retinal neurons, but in mature neurons 
ppt1 and sv2 were found abundantly in the presynaptic terminals (data not shown). 
localization of ppt1 in axonal presynaptic terminals and associated with vesicular 
structures was also confirmed by double labeling with synaptophysin and postembed-
ding immunoelectron microscopy (i, fig.5B and 6a-f)
to quantify the axonal distribution of ppt1, mature hippocampal neurons were in-
fected with a semliki forest virus expressing recombinant human ppt1 and analysed 
by immunofluorescence (i, fig. 4B). By using sfv-mediated expression, the start 
and duration of ppt1 expression could be controlled. sfv-mediated ppt1 intracel-
lular distribution did not differ from endogenous. Quantitative measurements were 
performed in cells representing mature stage 4 to 5 neurons. Quantification resulted in 
over threefold higher pixel intensities in axons compared to dendrites (p < 0.0001; i, 
fig. 4c) showing clear polarization of ppt1 distribution to axons.
this study showed a polarization of ppt1 distribution to axons in neurons. the spe-
cific localization of ppt1 in axons was further pinpointed to axonal varicosities with 
synaptic markers. the distribution data together with the high enzyme activity in ma-
ture neurons gave strong implications of the importance of ppt1 in functions outside 
the lysosomes in neurons. in addition, ppt1 was shown to precede mature synaptic 
markers in forming synapses and ppt1 activity was found to be under developmental 
regulation increasing upon neuronal maturation. these data together indicated that 
ppt1 is important both in the formation and the maintenance of synaptic contacts.
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2.  PPT1 deficiency causes endocytic defects 
connected to abnormal saposin processing (II)
endocytic abnormalities have been shown to be present in non-neuronal cell types 
of neurodegenerative diseases (cataldo, et al. 2000; metzler, et al. 2001), classical 
lysosomal storage diseases (chen, et al. 1998) and other diseases of the ncl group 
(heine, et al. 2004; luiro, et al. 2004). this study was initiated to clarify if such 
abnormalities were present also in incl cells. the hallmark of the incl disease is 
the accumulation of autofluorescent lipopigments, consisting of massive amounts of 
specific saposins a and d. the molecular mechanisms causing this have remained 
elusive. prior to this study the localization of the saposin species had only been char-
acterized on tissue level (tyynelä, et al. 1993). the aims of this study were to point 
the exact intracellular localization of the saposin species in cells lacking ppt1, and to 
observe the fate of saposins along the endocytic pathway in incl cells.  
to investigate whether lack of ppt1 causes functional defects in the endocytic path-
way, ppt1-deficient incl patient fibroblasts were utilized. these cells were cho-
sen because, even though incl symptoms mainly arise from neuronal dysfunction, 
mechanisms of endocytic trafficking are relatively poorly understood in neurons. fur-
thermore, also non-neuronal cell types show storage deposits in the disease so defects 
were likely to be present as well. nearing the end of this study the Ppt1Deltaex4 knockout 
mouse model became available and the subcellular localization of different saposin 
species was examined in the mouse neurons as well.
2.1 Delayed fluid-phase endocytosis in PPT1-deficient cells
dissection of the function of the endocytic pathway was begun by studying the fluid-
phase endocytosis (macropinocytosis, cell drinking) in the skin fibroblasts of incl 
patients by following the uptake and endocytosis of a well characterized marker, fluo-
rescent fitc-conjugated dextran (shurety, et al. 1998; swanson, 1989). the cells 
were fed with fitc-dextran and the uptake and timeing of transport along the endo-
cytic pathway were analyzed using confocal microscopy. the degree of colocaliza-
tion between the fluorescent marker and organelle-specific markers were quantified 
at various time points.
55
colocalization of fitc-dextran with organelle specific markers eea-1 for early en-
dosomes and lamp-1 for late endosomes/lysosomes was quantified at 10, 20, 40 120 
min time points in 15 representative cells per cell type in three independent experi-
ments. co-localization values of normalized pearson correlation coefficients in three 
A representation of saposin biosynthesis and maturation pathways and consequences of endocytic inhibitor
application.
The saposins are derived from a common precursor (proSAP, 65 kDa). The precurson has that has two 
alternative trafficking routes: Major pathway in wt cells comprises transport from the trans-Golgi network (1),
through late endosomes (2) to lysosomes (3) cleavage occurring in late endosome and lysosomes. In the 
minor route the precursor is modified into a 73 kDa form (A) (proSAP, 73kDa) which is secreted (B) and 
traffics via the endocytic route (C,D) to lysosomes (E). Cleavage to four mature polypeptides (A, B, C and D, 
8–11 kDa) occurs along the endo/lysosomal transport.
Bafilomycin A1 (BA1) blocks the transport from endosomes to lysosomes (C-D-E) and to some extent from 
the TGN to lysosomes (1-3). 3-methyladenine (3MA) blocks transport from late-endosomes to lysosomes 
(2-3, D-E).
In INCL cells, major part of intracellular proSAP was in the 73 kDa form (A). BA1 and 3MA treatments increased 
the secretion of the 73 kDa proSAP (B). Also an intermediate intracellular cleavage product of 35–37 kDa (C)
was present in INCL cells and increased with BA1 and 3MA treatment.
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combined experiments showed a statistically significant difference at 20 and 40 min 
time points in fitc-dextran localization between wt and incl cells (student’s t 
test, p < 0.05) (ii, figs. 1a and B). fitc-dextran persisted in early endosomes in 
incl cells showing a delay in fluid-phase endocytosis. immunofluorescence stain-
ings showed that after 10 min of chase, fitc-dextran colocalized well with an early 
endosomal marker eea-1 in both wt and incl fibroblasts. at the chase times of 20 
and 40 min, in contrast, fitc-dextran was detected in late endosomes/lysosomes and 
not early endosomes in wt cells, (ii, figs. 1 c–d) but part of fitc-dextran was still 
retained in eea-1 positive early endosomes in incl cells (ii, figs. 1e–f). at 2 h of 
chase fitc-dextran was distributed in late endosomes/lysosomes in both wt (ii, figs. 
1g–h) and incl fibroblasts (ii, figs. 1i–J). 
2.2 Delayed receptor-mediated endocytosis 
in PPT1-deficient cells
receptor mediated endocytosis was investigated using two marker molecules: fluo-
rescent low-density lipoprotein (BodipY fl-ldl) and biotinylated transferrin.  for 
BodipY fl-ldl studies the fibroblasts were starved for lipoprotein to enhance 
marker uptake, and subsequently fed with BodipY fl-ldl for 15 min. the cells 
were then fixed immediately or chased up to 40 min and analyzed using double im-
munofluorescence staining and confocal microscopy. co-localization of BodipY 
fl-ldl with organelle markers was quantified at indicated time points in 10 repre-
sentative cells per cell type in three independent experiments. colocalization values 
of normalized pearson correlation coefficients in combined experiments showed a 
statistically significant difference between wt and incl cells at all time points (stu-
dent’s t test, p < 0.05) (ii, figs. 2a–B) showing delayed receptor-mediated endocy-
tosis. in wt cells, fixed directly after 15-min ldl internalization, ldl had already 
passed the eea-1 positive early endosomes and colocalized mainly with lamp-1 in 
the late endosomes/lysosomes (ii, figs. 2c–d). however, in incl cells, majority of 
the ldl colocalized with eea-1 and only minority of the signal overlapped lamp-
1 at this time point (ii, figs. 2c–d). at 20 min of chase, ldl was detected in late 
endosomes/lysosomes in wt cells (ii, figs. 2g–h). in the incl cells, ldl was also 
detected in lysosomes (ii, fig. 2J), however, some ldl still remained in the eea-1 
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positive early endosomes (ii, fig. 2i). these data showed that also the receptor-medi-
ated endocytosis is delayed in incl cells. 
observed endocytic abnormalities were not caused by abnormal fusion or segrega-
tion of endocytic compartments in incl cells, as immunofluorescence analysis of 
lysosomal marker aspartylglucosaminidase, aga (ikonen, et al. 1991) and endosomal 
marker eea-1 showed that markers of different endocytic compartments in incl 
cells segregate properly (ii, fig. 3a). also fully functional endocytosis marker entry 
into the cells was verified by quantifying fitc-dextran and BodipY fl-ldl uptake 
(ii, figs. 3B–c). 
2.3 The recycling endocytosis pathway 
unaffected in PPT1-deficient cells
to examine the effect of different ppt1 expression levels on receptor-mediated endo-
cytosis and the recycling pathway, endocytosis and recycling of transferring was in-
vestigated using biotinylated transferrin and a solid phase assay. Biotinylated transfer-
rin was loaded into the cells at 17°c followed by a chase at 37°c to allow internalised 
transferrin to be recycled back into the extracellular space. the amount of biotinylated 
transferrin left inside the cells was measured at indicated time points using a quantita-
tive elisa assay. 
to study the effects of ppt1-deficiency and over expression, transferrin recycling 
was compared in wt fibroblasts, stably transfected cho cells (lehtovirta, et al. 2001) 
and incl patient fibroblasts. the patient cells exhibited no detectable changes in 
the rate of recycling when compared to wt (ii, fig. 4a). protein palmitoylation has 
been shown to affect the recycling rate of the transferrin receptor. alvarez and col-
leagues (alvarez, et al. 1990) have reported a significant increase in the endocytosis 
rate of palmitoylation defective transferrin receptor as compared to the wt receptor. 
however, no difference in the rate of recycling could be detected in ppt1-overex-
pressing cho-ppt1 cells when compared to wt cho cells. cho-ppt1 cells were 
also indifferent from cho-aga cell line over expressing another lysosomal enzyme 
aspartylglucosaminidase (ii, fig. 4B). to conclude, neither lack nor overexpression of 
ppt1 has an effect on the endocytic recycling pathway.
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similar abnormalities in specific endocytic pathways as observed here in incl were 
also published in another ncl disease Jncl (CLN3), around the time of this study 
(luiro, et al. 2004). also in the variant form of lincl (CLN6) defects in lysosomal 
degradation of arylsulfatase a marker were reported (heine, et al. 2004). interestingly 
the primary functions of these ncl proteins are proposed to be different and yet de-
fects caused by the lack of these proteins result in similar effects on cell function. the 
exact reason for this is not entirely clear but one explanation might be that the ncl 
proteins have their normal function on a common cellular pathway. in fact, recent 
investigations have revealed molecular interactions between several ncl proteins, 
further implicating the presence of common mechanisms and possible shared path-
ways (vesa, et al. 2002; Jalanko a., personal communication). 
growing body of evidence suggests that ppt1 has a function possibly in the regula-
tion of certain intracellular membrane trafficking events. the protein’s localization in 
places of active membrane transport in neural cells, the enzymatic depalmitoylation 
function a known regulator of trafficking events and here presented trafficking defect 
brought on by lack of the protein all point to this direction. the exact mechanism 
remains unclear however the trafficking defect present in ppt1 deficient cells most 
probably contributes to the neurodegenerative process in incl. 
2.4  SAPs A and D are redistributed in INCL fibroblasts  
and Ppt1Deltaex4 mouse knockout neurons
to elucidate the defective cellular pathway resulting in the specific accumulation of 
saposins a and d in incl cells, the different saposin species were studied in wt 
and ppt1 deficient cells. firstly, the subcellular distribution of prosap and saposins 
a–d was studied by double immunofluorescence stainings and confocal microscopy 
in incl fibroblasts and ppt1 Ppt1Deltaex4 mouse primary hippocampal neurons. the 
distribution of both sap a and d were strikingly different in incl fibroblasts com-
pared to wt fibroblasts. in wt cells, saposin d colocalized with a subpopulation of late 
endosomal/lysosomal vesicles identified by the markers lamp-1 and lBpa (ii, figs. 
5a–B), but not with eea1-positive early endosomes (ii, fig. 5c). in incl cells, sap 
d showed a more abundant staining appearing relocalized throughout the cells co-lo-
calizing extensively with late-endosomes and also partially with early endosomes (ii, 
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figs. 5d, e, f). the localization of sap B and c was similar in both wt and incl fi-
broblasts, showing a colocalization with subpopulations of late endosomal/lysosomal 
lamp-1 positive vesicles (ii, figs. 5g, h). Quantitation of the number of vesicles con-
taining sap a in wt and incl cells showed a statistically significant increase of vesi-
cles (p < 0.05) in incl cells (ii, fig. 5i). saposin a was also relocalized in Ppt1Deltaex4 
mouse neurons, whereas saposin B showed a distribution indifferent from wt. in wt 
control cells, sap a was localized in a subpopulation of late-endosomes/lysosomes 
as indicated by colocalization with lamp-1 (ii, fig. 6a). in contrast, in the Ppt1Deltaex4 
neurons, sap a was partially localized in late-endosomes/lysosomes but was also 
seen in a more diffuse pattern appearing in other vesicular structures in the cell soma 
(ii, fig. 6B), in a similar manner to ppt1-deficient fibroblasts. the staining pattern of 
sap B was same in control (ii, fig. 6c) and Ppt1Deltaex4 (ii, fig. 6d) neurons, showing 
a lysosomal distribution
2.5 Endocytic processing of saposins is 
abnormal in INCL fibroblasts
as abnormalities were found in transport of different markers along the endocytic 
pathway in incl cells it was of interest to see is saposin processing was affected as 
well. the saposins are all derived from a common precursor (prosap, 65 kda) that has 
two alternative trafficking routes: it is either transported directly from the trans-golgi 
network to the lysosomes or takes the alternative route in which case it is modified 
into a 73 kda form, secreted and traffics via the endocytic route to lysosomes. in the 
endo-lysosomal compartment the precursor is proteolytically cleaved to the four ma-
ture polypeptides, saps a, B, c and d (8–11 kda) (fürst, et al. 1992; hiesberger, et 
al. 1998; sandhoff and Kolter, 1997). the details of the cleavage process, exact order 
of events, as well as the specific compartment in which it takes place, are still poorly 
characterized (vielhaber, et al. 1996). the different saposin species were studied by 
metabolical labelling followed by immunoprecipitation in normal steady-state condi-
tions and in the presence of pharmacological agents affecting endocytosis. treatment 
with bafilomycin a1 (Ba1) specifically inhibits vacuolar h+-atpases resulting in the 
neutralization of endosomal ph, which blocks the transport from endosomes to lyso-
somes (Bowman, et al. 1988) and results in enhanced secretion of prosap (vielhaber, 
et al. 1996). 3-methyladenine (3ma) inhibits protein transport from late-endosomes 
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to lysosomes in a ph-independent manner (punnonen, et al. 1994). the saposin matu-
ration pathways and the effect Ba1 and 3ma has on them are presented in figure 6.
in the wt cells, the prosap was found mainly as a 65kda form and only a small frac-
tion of the precursor was found as a secreted 73kda form (ii, fig. 7a). Ba1 treatment 
increased the amount of the secreted 73kda form of the precursor in wt cells (ii, fig. 
7a). interestingly, in the incl fibroblasts, the intracellular prosap was mostly found 
in the 73kda form and hardly any 65kda precursor was detected (ii, fig. 7B). addition 
of Ba1 or 3ma also increased the secretion of the 73kda prosap in incl cells. in 
contrast to the wt cells, also the untreated incl cells showed an increased amount of the 
secreted 73kda prosap (ii, fig. 7B). in addition, immunoprecipitation of the prosap 
from the incl cells revealed a presence of an unexpected doublet band of 35–37kda in 
incl cells (ii, fig. 7B). treatment with Ba1 or 3ma further increased the intensity of 
this intracellular band, but it was not found in culture the medium (ii, fig. 7B). 
these studies show that there is an inherent shift of prosap equilibrium to the indirect 
maturation pathway in the incl cells, which is further enhanced by an endocytic in-
hibitor. also the major part of prosap in incl cells is directed to the indirect matura-
tion pathway. increased secretion and endocytosis of prosap has been reported from 
fibroblasts of i-cell disease patients that lack the ability to phosphorylate mannose 
residues (fujibayashi and Wenger, 1986; Kornfeld and mellman, 1989; vielhaber, et 
al. 1996). also, addition of the endocytic inhibitor bafilomycin, which alkalinizes the 
endosomal ph by 0.7–1.9 ph units (presley, et al. 1997; van Weert, et al. 1997) has 
been reported to enhance the secretion of lysosomal enzyme precursors including pro-
saposin secretion by the neutralization of the ph of endosomes (clague, et al. 1994; 
presley, et al. 1997; van Weert, et al. 1997). efficient uptake, processing and targeting 
of a number of secreted lysosomal enzymes, are heavily dependent on ph gradients. 
incl fibroblasts inherently exhibit a bafilomycin-like effect as seen by the hyperse-
cretion of prosap. the ph in the lysosomes of incl patient cells has been shown to 
be elevated (holopainen, et al. 2001) and altered trafficking pathway of prosap in 
incl cells could be in part associated with the alkalization of endosomal ph. how-
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ever, it is not the only reason leading to relocalization of saposins a and d and the 
abnormal processing of prosap, since also the ph independent agent 3ma induced 
a similar effect in incl cells. the sensitivity of prosap processing to 3ma in incl 
cells implies a defect in the vesicular fusion processes as 3ma is known to inhibit 
the fusion of late endosomes and lysosomes (punnonen, et al. 1994). the abnormal 
processing of prosap, and accumulation of the 35-kda processing intermediate, may 
actually be the outcome of a delay in the processing of prosap, supporting also the 
finding that endocytic events are delayed in incl.
it is not clear why the maturation defect and subsequent relocalization and abnormal 
accumulation apply only to saposins a and d and not saposins B and c in incl. 
slowdown of endocytic trafficking in incl cells could render the early maturation 
process of prosap more vulnerable leading to abnormal cleavage intermediates. it 
could also result in an abnormal accumulation of the cleavage products on the en-
docytic pathway, explaining relocalization of saposins. it is possible that saposins a 
and d are more vulnerable to processing in earlier endocytic structures due to delays 
in endocytosis or changes in the ph, since they are located in the distal parts of the 
prosap polypeptide chain.
this study established that lack of ppt1 causes specific endocytic defects in patient 
cells. importantly, also abnormal saposin processing and relocalization was shown for 
the first time. 
the exact nature of the endocytic defect, however, still remains unclear and further 
studies will be needed to characterize these events especially in neuronal cells. it will 
be of interest in the future to study why saposins a and d are specifically accumulated 
in incl and not other ncls, which also shows endocytic defects (heine, et al. 2004; 
luiro, et al. 2004).  studies will hopefully shed light on the detailed action of ppt1, 
saposins and other vesicular proteins and their contribution to the specific pathoge-
netic mechanism where the lack of ppt1 leads to neuronal death in incl. 
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3.  Palmitoyl protein thioesterase 1 (Ppt1) 
deficient mouse neurons show alterations in 
cholesterol metabolism and Ca2+ homeostasis 
prior to synaptic dysfunction. (III)
this study was started at a time when Ppt1deltaex4 knockout mouse model had become 
available and preliminary studies on whole animal and tissue level had been initiated. 
the mouse had tissue pathology identical to the human counterparts but otherwise 
the phenotype seemed somewhat milder than in the human disease (Jalanko, et al. 
2005). events at the cellular level, especially in neuronal cells, needed clarification 
and functional studies commenced. sensitive tools were needed for characterization 
of neuronal function and electrophysiological recordings, intracellular calcium home-
ostasis studies and different cellular stress inducing factors were chosen by virtue of 
their ability to show small dynamic changes in neuronal function. also specific cel-
lular metabolic processes were studied.
the genetic background of the incl disease was discovered already in 1991 (Järvelä, 
et al. 1991), however, as is the case for many lysosomal storage disorders, the specific 
affected cellular and biochemical pathways and downstream secondary events have 
remained elusive. in order to find the early affected metabolic pathways global gene 
expression profiling combined with statistical and pathway analysis was utilized. 
microarray studies were carried out with embryonic Ppt1deltaex4 neuron and wt control 
neuron cultures. 
3.1 Neuronal communication, maturation and lipid metabolism 
implicated in transcript profiling of Ppt1Deltaex4 neurons
global gene expression analysis of approximately 14 000 known mouse genes in 
cultured cortical Ppt1deltaex4 and wt control mouse neurons showed 135 statistically 
significant differentially expressed genes with false recovery rate of 1%. of the iden-
tified genes, 106 were up-regulated and 29 down-regulated (iii, table 1.). the most 
up-regulated	genes	were	synuclein	α	(Snca) with a fold change of +123 and adenyl-
ate cyclase-associated protein 1 (Cap1) with a fold change of +22. cap1 is a capping 
protein associated with the actin cytoskeleton. snca is localized at the presynaptic 
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sites in synaptosomes and has many functions in neurons including regulation of neu-
rotransmitter secretion, maintenance of functional integrity of synaptic transmission, 
regulation of synaptic plasticity, synaptic vesicle transport and phospholipid metabo-
lism (golovko, et al. 2005; liu, et al. 2004; rochet, et al. 2004). Snca is up-regulated 
in many neurodegenerative disorders, including several diseases of the ncl group 
and has neuroprotective qualities (leng and chuang, 2006). the most down-regulated 
gene (-3,6) was Shmt1, encoding a soluble serine hydroxymethyl transferase that is 
critical for the synthesis of numerous cellular constituents required for cell growth. 
further analysis of the array data was carried out using gene ontology tree machine 
tool-kit according to gene ontology (go) classifications (ashburner, et al. 2000). 
the gene ontology analysis showed significantly more genes observed than expected 
(P<0.01) in 42 categories as follows: in biological processes three major pathways 
(iii, fig. 1 a), one molecular function (iii, fig. 1B) and in cellular compartments 
three distinct compartments (iii, fig. 1c). the affected biological processes were 
cell communication, specifically secretion and transmission of the nerve impulse, also 
development, specifically neuron maturation and ensheathment, and in cellular meta-
bolic process the lipid metabolism. the molecular function with significant changes 
was binding, specifically calcium ion binding, lipid binding, identical protein binding 
and steroid binding (iii, fig 2.). the aspects of the implicated pathways were func-
tionally analysed as described below.
3.2 Enhanced proliferative capacity of 
Ppt1Deltaex4 progenitor/stem cells
to understand early events in neuronal maturation and their potential consequences to 
incl pathology, we studied neuronal stem cell maturation in culture. the prolifera-
tive capacity of the progenitor/stem cells as well as their maturation into various cell 
types was assessed.  proliferating neurospheres were dissociated and plated followed 
by a cyQuant cell proliferation assay after 12 hours. in the high density experiments 
(initial 5000 cells per plate) the difference between Ppt1deltaex4 and wt cells reached 
statistical significance (iii, fig. 3a). Ppt1deltaex4 brain stem cells further exhibited nor-
mal differentiation capacity forming mature cell types present in the central nervous 
system: neurons (neun staining iii, fig. 3B), astrocytes (gfap staining, iii, fig. 3c), 
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oligodendrocytes (galc staining, iii, fig. 3d) and microglial cells (f4/80 staining, 
iii, fig. 3e). neurite length was also studied as a marker for normal neuronal differ-
entiation and was found to be similar in both wt and Ppt1deltaex4 progenitor/stem cell 
derived neurons. 
3.3  KO mouse neurons show fundamental 
changes in the cholesterol metabolism
microarray studies showed upregulation in lipid metabolism, specifically in the me-
tabolism of cholesterol and its derivatives and isoprenoid metabolism. several choles-
terol biosynthesis pathway key players, including the 3beta-hydroxysterol delta (14)-
reductase acting at late steps of cholesterol biosynthesis, were upregulated. these 
findings prompted us to study cholesterol biosynthesis and steady state cholesterol 
content in Ppt1deltaex4 mouse neuron cultures compared to wt neurons.
the changes seen in microarray analysis did manifest on the functional level in neuron 
cultures. the rate of sterol synthesis was found to be upregulated Ppt1deltaex4neurons 
compared to wt. especially the conversion of sterols into the end product cholesterol 
and its immediate precursor desmosterol was markedly upregulated in Ppt1deltaex4neu-
rons (iii, fig. 4a). When total sterol amounts were analyzed, we found that cholesterol 
was unchanged in Ppt1deltaex4 neurons as compared to wt but the amounts of its immedi-
ate precursors were reduced (iii, fig. 4B). this result agrees with the enhanced conver-
sion of precursor sterols into the end product as observed with radiolabeled sterols. 
the amount of unlabeled lanosterol was also reduced in the Ppt1deltaex4 neurons. this 
tendency	is	in	line	with	the	upregulation	of	3β-hydroxysterol	Δ(14)-reductase	mRNA	
as this is a post-lanosterol enzyme in sterol biosynthesis. these findings may reflect the 
leakage of cholesterol out of the cells into the growth medium. While the exact molecu-
lar mechanisms underlying these changes remain unclear they may have fundamental 
effects on neuronal function.  defects in cholesterol metabolism have been implicated 
in neurological defects in several diseases (vance, hayashi, and Karten, 2005). in the 
niemann-pick type c (npc) disease impaired cholesterol transport causes neurologi-
cal symptoms resulting from accumulation and cellular imbalance of cholesterol. the 
imbalance is manifested in neurons by reduced cholesterol content in the axons causing 
synaptic dysfunction.  it has also been reported that npc fibroblast cells have traffick-
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ing defects leading to increased cholesterol synthesis and expression of ldl receptors. 
(reviewed in liscum and sturley, 2004) impairments in intracellular trafficking are also 
shown in incl fibroblasts in this thesis work and earlier also in other ncl fibroblasts 
(ahtiainen, et al. 2006; luiro, et al. 2004). these include slowdown in the transport rate 
of labelled ldl in the endocytic route. if this defect is also present in neuronal cells it 
might have an impact on cholesterol homeostasis.
cholesterol is also a regulator of neuronal development being essential for axonal 
growth and repair (posse de chaves, et al. 2000; trommsdorff, et al. 1999). abnor-
malities present in the cholesterol metabolism may have developmental implications 
in incl. amount and ratio of cholesterol and it’s precursors change the fluidity of the 
membrane in which they reside (vance, et al. 2006). changes in this balance possibly 
affect developmental processes in neurons such as axonal extension. as cholesterol is 
important in spatial organization, fusion and recycling of synaptic vesicles (Jia, et al. 
2006; Jeremic, et al. 2006), another possibility is that the increased cholesterol bio-
synthesis in Ppt1Deltaex4 neurons serves to preserve functional synapses. the upregula-
tion of cholesterol biosynthesis may by a secondary phenomenon resulting from the 
primary ppt1 deficiency.  however, it is possible that the changes observed here in 
the sterol balance of Ppt1Deltaex4 neurons may reflect compensatory mechanisms to pre-
serve raft integrity and functions since altered levels of ppt1 expression have previ-
ously been associated with altered lipid composition of rafts (goswami, et al. 2005). 
3.4 KO mouse neurons recover more readily  
from glutamate induced Ca2+ release
defects in maintenance of intracellular calcium homeostasis have been previously 
reported in neurodegenerative disorders (albin, 2003; etcheberrigaray, et al. 1998; 
ho, et al. 2001; mandel, et al. 2003). observing maintenance of calcium homeostasis 
is a sensitive tool to study subtle dynamical changes in neuronal function. microarray 
analysis of Ppt1deltaex4 mice also showed significant changes in transcripts encoding 
calcium binding proteins of which significantly up-regulated are shown in table 2 
(iii, table 2).
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to test functional properties of Ppt1deltaex4 mouse neurons primary embryonic cortical 
and hippocampal mixed neuron cultures were utilized for the study in intracellular 
ca2+ homeostasis using the calcium indicator fura-2. Wt and Ko cultures accumu-
lated the dye with similar efficiency. Both cultures responded similarly to depolariza-
tion induced by 50 mm K+ (fura-2 340/380 ratio: 2.9±0.3 versus 3.4±0.3, n=70 and 
96 cells in Ko and wt, respectively; p>0.05). after full recovery of ca2+ back to the 
pre-stimulation	baseline,	cells	were	challenged	with	100	μM	glutamate.	Although	glu-
tamate-induced peak ca2+ levels were similar between wt and Ppt1deltaex4 cells, post-
glutamate recovery of ca2+ to the baseline was different in that Ppt1deltaex4 cells recov-
ered more efficiently that their wt counterparts. to quantify these results, we analysed 
glutamate responses in cells that responded to the initial stimulation with elevated K+. 
among the cells that responded to glutamate, 47±11% of Ppt1deltaex4 cells returned to 
their pre-stimulation ca2+ levels, while only 27±9% of wt cells were able to recover to 
baseline ca2+. at the end of each experiment, culture dish was perfused with the iono-
phore	ionomycin	(50	μM),	and	the	340/380	ratio	corresponding	to	the	maximal	Ca2+ 
level was found to be similar between Ppt1deltaex4 and wt cells (5.6±0.5 and 6.2±0.6, 
respectively; p>0.05). thus, despite similar properties of basic ca2+ homeostasis, Ppt-
1deltaex4 cells exhibited a tendency to improved recovery after a potentially excitotoxic 
stimulation with glutamate, as compared to wt cells.
the reason for this tendency for more efficient recovery exhibited by Ppt1deltaex4 neu-
rons is not altogether clear but a contributing factor may be the up-regulation of sev-
eral transcripts encoding calcium binding proteins, found in the microarray analysis 
of Ko mouse neuron cultures. some of these calcium binders are directly associated 
with protection of glutamate induced cytotoxicity such as calbindin1. also other less 
specific factors reported to have neuroprotective activities, such as synuclein alpha, 
were also up-regulated in the arrays possibly providing additional protection from 
activity induced stress and cytotoxicity. it has been proposed that er stress mediated 
unfolded protein response would lead to impairment in the maintenance of calcium 
homeostasis in incl. er stress, possibly caused by accumulation of palmitoylated 
substrates, would also induce reactive oxygen species (ros) increase leading to mi-
tochondrial membrane dysfunction and following caspase-9 activation and apopto-
sis. (Kim, et al. 2006b). We could not, however, find implications of mitochondrial 
dysfunction or increased ros nor did we detect increase in apoptosis in cultured 
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neuronal cells (data not shown). one explanation for the observed efficient recovery 
and resistance to cytotoxicity could be that Ko cells are less responsive to glutamate 
induction per se, possibly due to decrease in the number of glutamate receptors or 
their activity. however, this does not seem to be the case since peak levels of released 
calcium at induction are similar in Ppt1deltaex4 and wt cells. also glutamate receptor 
abnormalities would also be expected to be manifested in defects in synaptic function. 
however synaptic function is unaffected as shown in following. 
3.5 Ppt1Deltaex4 hippocampal CA1 neurons have unaltered  
active electrophysiological properties in young mice
the microarray analysis results strongly pointed to changes in factors that affect syn-
aptic function including significant changes in gene categories encoding factors that 
regulate neurotransmitter secretion and neurotransmitter levels, synaptic transmis-
sion and action potential regulation, nerve ensheathment and myelination. to assess 
whether lack of ppt1 has an impact on synaptic function we studied the active elec-
trophysiological properties of Ppt1deltaex4 mouse neurons in acute brain slices in the 
ca1 region pyramidal neurons.  the Ppt1deltaex4 neurons exhibited unchanged basic 
conductive properties as indicated by similar synaptic delay values in wt and Ppt1del-
taex4 neurons (wt 5.5ms ± 1.1, n=8; Ko 6.9ms ± 0.8, n=8; p>0.05). also the properties 
of stimulation-induced epsps amplitude, the slope, rise and decay times were similar 
(iii, fig. 5a).
to characterize efficacy of synaptic transmission, stimulation-response curves ob-
tained from wt and Ppt1deltaex4 neurons. schaffer collaterals were stimulated with in-
tensities ranging from 2mv to 30mv and the amplitude of synaptic response was 
measured. Wt and Ppt1deltaex4 neurons showed identical stimulation-response relation 
(iii, fig. 5B). they had a similar threshold for initial response and a similar slope of 
the stimulus-response curve. furthermore, the largest possible response did not differ 
in wt and Ppt1deltaex4 neurons (iii, fig. 5 B).
properties of short-term synaptic plasticity between Ppt1deltaex4 and wt neurons were 
compared by measuring paired-pulse responses with increasing inter-stimulus inter-
vals. no differences could be found in short term plasticity measured by paired pulse 
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responses in wt and Ppt1deltaex4 neurons (iii, fig. 5 c). the rate of depletion of the 
readily releasable pool of synaptic vesicles during repeated stimulation was studied 
by tetanic stimulation causing progressive depletion of the synaptic vesicle. Both Wt 
and Ppt1deltaex4 neurons responded similarly to repeated stimulation. the plateau of 
109.6pa (± 28.6, n=11) for wt and 125.2pa (± 38.2, n=8) for Ppt1deltaex4 were reached 
at 267ms (±27) and 261ms (±27) respectively (iii, fig. 5 d).
Based on the thorough analysis of 16 to 25 day old mouse hippocampal ca1 region 
pyramidal neurons it is clear that lack of ppt1 does not affect the active electrophysi-
ological properties of this particular neuron type at this time point. previous findings 
on the mouse model and also data on the patients suggest that even though storage 
material is present in a very early time point, even prenatally, gross changes in neu-
ronal function and neuronal death start at a later time. the mice show loss of vision 
not until the age of 8 weeks, seizures after 4 months and paralysis of hind limbs at 
the age of 5 months (Jalanko, and vesa, et al, 2005). so it likely that regulation of 
neuronal function is so crucial, that compensatory mechanisms mask the events of 
early pathogenesis in young animals. this is also supported by the findings in the 
other Cln1-/- mouse model: the Ppt1tm1Hof−/− mouse cultured embryonic neurons have 
increased lysosomal ph, normal synaptic density but reduced number of readily re-
leasable pool of synaptic vesicles. in spite of this, they exhibit unchanged active elec-
trophysiological properties (virmani, et al. 2005). also a contributing factor, to the 
unchanged electrophysiological findings reported in this study, may be a differential 
selective pattern of neurodegeneration in the hippocampus: incl patients have been 
reported to have significant degeneration in the ca2, ca3 and ca4 regions of the 
hippocampus whereas the ca1 region is relatively spared (tyynelä, et al. 2004). neu-
roanatomical studies of the Ppt1tm1Hof−/− mice implicated that the selective neuronal 
loss in incl most dramatically influences the somatosensory cortex and thalamus 
(Bible, et al. 2004). it is also plausible that initiation neuronal death in the disease has 
a threshold; cells are able to tolerate and compensate cellular defects up to a certain 
point, after which pathogenetic mechanism take over. this can further be inferred 
from the fact that non-neuronal cells are mostly not affected in incl even though 
cellular defects, such as delays in specific endocytic pathways and abnormalities in 
storage protein metabolism, are present in them too (ahtiainen, et al. 2006). neurons 
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may be more vulnerable to these defects due to their restricted regenerative potential 
and more complex cellular metabolism.
the specific mechanisms of neuronal death present in incl still remain unsolved. the 
selective pattern of neuronal loss implies the presence of specific mechanisms and in 
fact increased caspase cascade mediated apoptosis has been reported on Ppt1tm1Hof−/− 
mice and patient tissue (Zhang and Kaufman, 2006). however, while cultured Ppt-
1Deltaex4 embryonic show definite changes in several cellular functions, no increase is 
observed in the rate of apoptosis nor necrosis in steady state or cellular stress inducing 
conditions (Kopra o., unpublished observations). moreover, connections to regula-
tion of autophagic processes arise from the fibroblast studies (ahtiainen, et al. 2006): 
alterations in fluid-phase endocytosis and effects of the autophagic inhibitor 3ma on 
metabolism in ppt1 deficient cells. recent studies have associated autophagic events 
to apoptotic cell death (guillon-munos, et al. 2006; Yu, et al. 2004). as many key 
players are shared by these pathways it is plausible that different modes of cell death 
also act in concert in incl.     
this study established that lack of ppt1 has fundamental effects on neuronal func-
tion. ppt1 is crucial in neuronal maturation and development and also in the function 
of mature neurons. lack of ppt1 has an impact on many cellular functions directly 
or indirectly including lipid metabolism, maintenance of calcium homeostasis and 
early proliferation. these studies showed for the first time that ppt1 deficiency causes 
fundamental defects in neuronal cholesterol biosynthesis and the connection between 
ncl and lipid metabolism deserves more attention in the future.
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Conclusions and future prospects
When this study was initiated the genetic background of the ncl disorders had been 
elucidated to a large extent, through identifying genes behind the diseases and a 
number of disease causing mutations. however the biological processes and func-
tional defects underlying disease mechanisms were still poorly understood. the focus 
of research shifted towards better characterizing early events in disease progression 
through functional and cell biological approaches. the first approaches utilized pa-
tient cell models. however, major advances in the understanding the molecular ba-
sis of ncls, came through the emergence of genetically engineered mouse disease 
models. in recent years, thorough characterization of the mouse models has revealed 
new aspects of disease neuropathology and defects in cellular processes underlying 
neurodegeneration have started to unfold. also utilizing system wide approaches and 
high-throughput methods has provided new avenues of research and advances have 
also been made in discovering potential therapeutic approaches. in spite of these ma-
jor advances, still fairly little is understood of the connections of primary enzyme de-
fects leading to storage of intracellular material and the following downstream effects. 
therefore the impact the intracellular storage on neuronal function is only beginning 
to be understood.
the major findings in this thesis work include the characterization of ppt1 localiza-
tion in mature synapses and expression patterns in early neuronal maturation stressing 
the importance of ppt1 to neuronal maturation as well as mature neuronal function. 
furthermore we present the first connection of intracellular storage material to defects 
in endocytic transport in patient cells. early events underlying disease pathology were 
discovered through high-throughput methods, and confirmed in functional studies of 
the ppt1 deficient mouse disease model. these defects included changes in early mat-
uration and impact on cholesterol and calcium metabolism. similar defects have been 
found to contribute to pathology in other lsds as well as neurodegenerative disorders 
(Korkotian, et al. 1999, lloyd-evans, et al. 2003; pelled, et al. 2003; Jeyakumar, et al. 
2005). further characterization and better understanding of the molecular basis and 
the exact mechanisms of these defects will be of utmost importance in future studies. 
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thorough tissue level neuropathological and neuroanatomical investigations on the 
disease model mice have revealed specific patterns of neuronal death in ncls. the 
cortical neurons are most affected in the ncls, however there are prominent differ-
ences between the severity of neurodegeneration in different cortical layers and fur-
thermore between resident neuron populations. the first signs of neurodegeneration 
are present, not in the cortical area, but in the thalamic region (Bible, et al. 2004; pon-
tikis, et al. 2004; Weimer, et al. 2006). these findings have lead to reassessment of the 
sequence of events leading to neuronal death in the ncls.  the thalamus has an im-
portant role as a relay center for sensory inputs to the cerebral cortex from the periph-
ery. the cortical lamina iv pyramidal neurons in the primary sensory cortices receive 
input from the thalamus and these cells are severly affected in the incl mouse model. 
it is plausible to assume that neuronal connections play a role in incl pathology. in 
addition, loss of inhibitory gaBaergic interneurons in several brain areas implies de-
fects in maintenance of the balance of inhibitory and excitatory inputs contributing to 
neuronal dysfunction and death (gupta, et al. 2001; Jalanko, et al. 2005). localization 
and identity of the neuron are central determinants of neuron survival in incl and 
calcium related functions and their alterations are a strong candidate in this process 
(das, et al. 1999; haltia, et al. 2001; d’orlando, et al. 2002; cooper, 2003; Kim, et 
al. 2006; cooper, et al. 2006). further studies defining processes, that render specific 
neuronal populations more vulnerable, are needed. some controversy exists on neu-
ronal death mechanisms in incl. suggested models include apoptosis and autophagy 
(mitchison, et al. 2004). of these, er stress induced apoptosis described in the mouse 
model as well as patient autopsy samples, is best characterized (Zhang and Kaufman, 
2006). it is probable that several mechanisms apply depending on the temporal and 
spatial context during disease progression. delineating the specific mechanisms of 
neuronal death, present in different neuron populations, will broaden the understand-
ing of the cascade of pathogenetic events in the disease.
growing evidence suggests that developmental issues, rather than just degenerative 
aspects, are central contributors to incl disease pathology. interactions of neural 
and glial cells in developing brain and in regulation of mature neuronal function may 
turn out to be central in incl. glial cells provide and maintain the local chemical 
environment necessary for proper neuronal function. pervasive astrocytic and more 
limited microglial activation are concurrent and even precede neurodegeneration in 
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incl (elshatory, et al. 2003). glial activation demarcates abnormal inflammatory 
responses, especially in later stages of disease progression, but glia may also play a 
role in early pathogenetic events. the role of lipid and calcium metabolism in neurons 
needs to be studied from the developmental viewpoint and also in relation to glial 
responses. furthermore, analysis of ppt1 in relation to other developmental players 
and synaptic proteins as well as other ncl proteins, utilizing high-throughput and in 
vivo functional methods, are essential understanding the events leading to neuronal 
degeneration and ultimately death in incl. these studies will provide information 
leading to understanding of the exact function and targets of ppt1 action in vivo.
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